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Schizophrenia and other psychoses are among the most severe medical diseases. 
There are few general population surveys of psychotic disorders. Most studies 
have focused on schizophrenia and bipolar I disorder, while data of many other 
specific psychotic disorders are scarce. 
This study investigated the lifetime prevalence and epidemiological features of 
psychotic disorders in the adult Finnish general population. The lifetime preva-
lence of psychotic disorders was higher than has been estimated in most recent 
general population studies. The most common disorder was schizophrenia. 
Psychoses were generally associated with socioeconomic disadvantage. The 
highest lifetime prevalence was found in northern and eastern parts of Finland, 
which should be taken into account when resources are allocated to health care. 
Alcohol-induced psychotic disorders were common in working aged men and 
associated with high mortality. Clinical features of delusional disorder were differ-
ent from schizophrenia. Disorganized schizophrenia was a schizophrenia subtype 
associated with poor outcome. With a high lifetime prevalence exceeding 3%, 
psychotic disorders are a major public health concern.
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Abstract 
Jonna Perälä. Epidemiology of Psychotic Disorders. National Institute for Health 
and Welfare (THL). Research 97/2013. 130 pages. Helsinki, Finland 2013. 
ISBN 978-952-245-825-4 (printed); ISBN 978-952-245-826-1 (pdf) 
 
Schizophrenia and other psychoses are among the most severe and impairing 
medical diseases. They often cause lifelong disability and the affected subjects have 
increased physical morbidity and shortened life expectancy. Only few general 
population studies of psychotic disorders have been conducted. These studies of 
psychotic disorders have been burdened with many methodological difficulties. 
Most epidemiological studies have focused on schizophrenia and bipolar I disorder, 
while data of many other specific psychotic disorders are scarce.  
 
This thesis investigated the lifetime prevalence and epidemiological features of 
psychotic disorders in the Finnish general population. The data were derived from 
the Health 2000 Study, a comprehensive general population survey of Finnish adults 
aged 30 years and over (N=8028). In the Psychoses in Finland study, the Health 
2000 Study sample was screened for psychotic disorders.  Those selected by the 
screens were invited for a mental health interview. Final best-estimate DSM-IV 
diagnoses were based on systematic evaluation of the interview and the case note 
data.   
 
The lifetime prevalence of any DSM-IV psychotic disorder was 3.5%. The most 
common psychotic disorder was schizophrenia. Non-affective psychoses were more 
common than affective psychoses. Substance-induced psychotic disorders were 
common among working aged men and psychotic disorder due to general medical 
condition among women aged 65 years or over. Psychotic disorders were generally 
associated with socioeconomic disadvantage like being unmarried, pensioned or 
unemployed; having low income or education level. Geographic distributions of 
psychotic disorders were assessed using university hospital regions and 
categorization of urban and rural areas for the place of birth and residence. The 
highest lifetime prevalence was found in northern and eastern, and lowest in south-
western parts of Finland. The region of birth was a more important determinant of 
the risk of psychotic disorders than the region of residence or urban-rural 
categorization, and most marked in schizophrenia.  
 
Clinical features of some specific psychotic disorders were studied in more detail. 
Alcohol-induced psychotic disorder was common among working age men. Low 
socioeconomic status, high comorbidity, high use of medical services and very high 
mortality were found among the affected subjects, even when compared to subjects 
with alcohol dependence but no psychosis. Delusional disorder was found to be a 
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different disorder from paranoid schizophrenia and was characterized by high age of 
onset, absence of other symptoms than delusions and relatively good outcome. 
Disorganized subtype of schizophrenia was associated with early onset, male 
preponderance, chronic course, long hospitalizations and poor outcome. Paranoid 
and undifferentiated schizophrenia resembled each other. 
 
In conclusion, psychotic disorders are more common in the general population than 
has been estimated in most recent general population studies. The high prevalence of 
psychotic disorders challenges the old interpretation of evenly distributed prevalence 
of psychotic disorders worldwide. These results of high and unevenly distributed 
prevalence of psychotic disorders provide tools for developing the health care 
systems. Best possible individual treatment and rehabilitation should be provided to 
minimize any disadvantage related to psychotic disorders. 
 
Keywords: Psychotic disorders, schizophrenia, alcohol-induced psychotic disorder, 
delusional disorder, lifetime prevalence, general population, geographic variation, 
epidemiology.  
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Tiivistelmä 
Jonna Perälä. Epidemiology of Psychotic Disorders [Psykoottisten Häiriöiden 
Epidemiologia]. Terveyden ja hyvinvoinnin laitos (THL). Tutkimus 97/2013. 130 
sivua. Helsinki, Finland 2013.  
ISBN 978-952-245-825-4 (painettu); ISBN 978-952-245-826-1 (pdf) 
 
Skitsofrenia ja muut psykoottiset häiriöt kuuluvat vaikeimpiin ihmiskuntaa 
kohtaavista sairauksista. Häiriöihin liittyy usein elinikäinen toimintakyvyn 
heikkeneminen, suuri fyysinen sairastavuus ja lyhentynyt elinikä. Psykoottisten 
häiriöiden esiintyvyydestä on tehty vain vähän väestötutkimuksia. Tutkimuksiin 
liittyy monia menetelmällisiä ongelmia. Useimmat epidemiologiset tutkimukset ovat 
keskittyneet skitsofrenian ja tyypin I kaksisuuntaiseen mielialahäiriöön. Monista 
muista psykoottisista häiriöistä on vain vähän väestötason tietoa.   
 
Tässä väitöskirjassa selvitettiin psykoottisten häiriöiden elämänaikaista esiintyvyyttä 
ja esiintyvyyteen liittyviä piirteitä suomalaisessa aikuisväestössä. Tutkimusaineisto 
perustuu kattavaan Terveys 2000 väestötutkimukseen yli 30 -vuotiaiden 
suomalaisten terveydentilasta ja toimintakyvystä (N = 8028). Psykoosit Suomessa -
jatkotutkimukseen seulottiin 746 osallistujaa käyttämällä tutkimusta varten 
kehitettyä psykoosiseulaa. Heidät kutsuttiin tarkempaan mielenterveyshaastatteluun. 
Mielenterveyshäiriöt diagnosoitiin DSM-IV -tautiluokituksen mukaisia diagnostisia 
kriteereitä käyttäen, hyödyntäen sekä haastattelu- että potilaskertomustietoja.  
 
Kaikkien psykoottisten häiriöiden elämänaikainen esiintyvyys Suomessa oli 3.5 %. 
Yleisin psykoosi oli skitsofrenia. Ei-mielialaoireiset psykoosit olivat yleisempiä 
kuin mielialaoireiset psykoosit. Päihdepsykoosit olivat yleisiä työikäisillä miehillä ja 
yleissairauteen liittyvät psykoosit yli 65-vuotiailla naisilla. Psykoottiset häiriöt olivat 
yhteydessä matalaan sosioekonomiseen asemaan. Erityisesti ei-mielialaoireiseen 
psykoosiin sairastuneet olivat useammin naimattomia, työttömiä ja eläkeläisiä tai 
alhaisten peruskoulutuksen ja tulotason omaavia kuin yleisväestö.  Psykoottisten 
häiriöiden alueellisia eroja tarkasteltiin viiden yliopistosairaala-alueen sekä 
kaupunki- että maaseutuympäristön välillä. Häiriöitä esiintyi eniten Pohjois- ja Itä-
Suomessa ja vähiten Lounais-Suomessa.  Syntymäpaikka oli asuinpaikkaa tai 
kaupunki- tai maaseutuympäristöä tärkeämpi psykoottisen häiriön ja erityisesti 
skitsofrenian riskiin vaikuttava tekijä.  
 
Tässä tutkimuksessa kartoitettiin tarkemmin tiettyjen psykoottisten häiriöiden 
piirteitä. Alkoholiin liittyvä psykoottinen häiriö oli erityisen yleinen keski-ikäisillä 
miehillä. Matala sosioekonominen asema, runsas samanaikaissairastuvuus, runsas 
terveyspalvelujen käyttö ja korkea kuolleisuus olivat yleisempiä alkoholipsykoosin 
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sairastaneilla kuin muilla alkoholiriippuvaisilla. Harhaluuloisuushäiriö erosi 
skitsofrenian alatyypeistä. Sille oli ominaista myöhäinen sairastumisikä, vähäinen 
muiden oireiden kuin harhaluulojen esiintyvyys ja suhteellisen hyvä ennuste. 
Hajanaisoireiseen skitsofreniaan liittyi varhainen sairastumisikä, miessukupuoli, 
krooninen kulku, pitkät sairaalahoidot sekä huono ennuste. Paranoidinen ja 
erilaistumaton skitsofrenia sen sijaan muistuttivat toisiaan. 
 
Tämän tutkimuksen perusteella psykoottiset häiriöt ovat yleisempiä kuin useissa 
viimeaikaisissa väestötutkimuksissa on arvioitu. Psykoottisten häiriöiden korkea 
esiintyvyys haastaa vanhan tulkinnan maailmanlaajuisesti tasaisesti jakautuneesta 
psykoottisten häiriöiden esiintyvyydestä. Tulokset psykoottisten häiriöiden 
esiintyvyyden alueellisesta vaihtelusta voidaan hyödyntää terveydenhuollon 
järjestelmiä kehitettäessä. Psykoottisiin häiriöihin liittyvät haitat tulisi minimoida 
tarjoamalla parasta mahdollista yksilöllistä hoitoa ja kuntoutusta.  
 
Avainsanat: Psykoottiset häiriöt, skitsofrenia, alkoholipsykoosi, 
harhaluuloisuuhäiriö, esiintyvyys, väestötutkimus, alueelliset erot, epidemiologia. 
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1 Introduction 
Although schizophrenia and other psychoses are not very frequent disorders, they 
are among the most severe and impairing medical diseases (Insel, 2010). Active 
psychosis was ranked the most disabling condition after quadriplegia and dementia 
in a WHO multi-country study (Ustün et al., 1999). Psychotic disorders cause 
enormous suffering for patients and their family members. As the average age of 
onset for many psychotic disorders is at the most critical period of educational, 
occupational and social development, their consequences often lead to lifelong 
disability. These patients also have increased physical morbidity and mortality 
compared with population without a psychotic disorder (De Hert et al., 2011, 
Kiviniemi et al., 2010, Saha et al., 2007, Tiihonen et al., 2009, 2012). Economic 
costs to society consist of the expense of treatment and loss of productivity. The 
costs of psychotic disorders were estimated to be the third largest of brain diseases 
in Europe in 2010, after mood disorders and dementia (Gustavsson et al., 2011).  
 
Schizophrenia and bipolar I disorder are the most common of psychotic disorders. 
Most studies of epidemiology have focused on them. However, other psychoses also 
cause long-term disabilities (Widerlöv et al., 1997), and the distinction between 
schizophrenia and other psychoses is still quite challenging (Dikeos et al., 2006). 
There are many studies investigating differences and similarities on genetics, brain 
structures, neuropharmacological mechanisms, neuropsychological functioning and 
environmental risk factors of psychotic disorders (Murray et al., 2004). Still, the 
pathogenesis of psychosis is far from fully understood. Thus, broader inclusion of 
psychotic disorders in epidemiological studies may be a useful agenda. 
 
Few population-based studies on psychotic disorders have been conducted in the last 
decades (Kendler et al., 1996, Kessler et al., 2005, van Os et al., 2001), many of 
them focusing on non-affective and affective psychotic disorders as groups. Only 
one study has estimated the prevalence of specific psychotic disorders (Bogren et al., 
2009). General population studies have faced increasing problems in case finding 
and ascertainment (Jablensky, 1995). Survey response rates have fallen, and people 
with psychotic disorders, especially schizophrenia, are less likely than others to 
participate in mental health surveys (de Graaf et al., 2000, Haapea et al., 2007, 
2008). Studies that are not able to use information other than from interviews seem 
to produce lower estimates compared with studies having access to other sources of 
information (Saha et al., 2005). Regardless of the problems, general population data 
are needed. If studies on psychotic disorders were based on clinical samples, our 
knowledge of psychotic disorders would be biased towards the most severe and 
chronic types of psychotic disorders.  
Introduction 
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The Psychoses in Finland (PIF) study is based on the Health 2000 Study, a general 
population survey of adults aged 30 years and over living in mainland Finland. It is a 
comprehensive general population survey of the prevalence of psychotic disorders in 
terms of diagnostic assessment and diagnostic coverage. The aim of this study was 
to report for the first time the prevalences of all specific psychotic disorders 
separately in one study. Besides determining the prevalence, sociodemographic 
correlates, regional distribution and clinical features of psychotic disorders which 
are investigated in this thesis, the aim of the PIF project was to study 
neuropsychological functioning, somatic comorbidity and its causes, functional 
disability, and quality of life in psychotic disorders.  
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2 Review of the literature  
2.1 Diagnostic classification of psychotic disorders  
Psychotic disorders have been classified according to different systems during the 
last 150 years (Tandon et al., 2009). Current psychiatric diagnostic classifications 
are based on operational diagnostic criteria. The goal of the operational diagnostic 
criteria is to define and describe the disorders in terms of simple signs and 
symptoms, which are externally observable and often behavioural symptoms. This is 
necessary as knowledge of aetiology in psychiatric disorders is still limited.  
 
Psychotic disorders according to the definition on the Diagnostic and Statistical 
Manual for Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR, 
American Psychiatric Association, 2000) are presented in Table 1. DSM-IV is 
currently the most often used diagnostic system in international research practice. 
Individual psychotic disorders are distinguished from each other based on the 
duration, dysfunction, type of delusions and hallucinations, presence of depression 
and mania, and associated substance use or medical condition.  
 
Psychotic symptoms are conventionally characterized to be the central features of 
schizophrenia and other non-affective psychotic disorders, while affective psychoses 
and secondary psychoses are often regarded as disorders where psychotic symptoms 
are present as an associated feature. In different psychotic disorders, different 
aspects of psychosis are emphasized. In schizophrenia, schizoaffective disorder, 
schizophreniform disorder and brief psychotic disorder psychotic symptoms include 
delusions, prominent hallucinations, disorganized speech and disorganized or 
catatonic behaviour. In psychotic forms of mood disorder, e.g. bipolar I disorder and 
MDD, delusions and hallucinations are the only symptoms included in the 
diagnostic criteria. In psychotic disorder due to general medical condition or 
substance induced psychotic disorder, only delusions and hallucinations without 
insight are regarded as psychotic. Thus, even between the DSM-IV diagnoses, the 
definition of psychosis is varying. Modifications to these definitions have been 
suggested for the DSM-V criteria that will be published in 2013 (Tandon, 2012). 
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Table 1.  Psychotic Disorders in the DSM-IV-TR (American Psychiatric 
Association,  2000)      
Non-affective psychotic disorders
Schizophrenia
Schizoaffective disorder
Schizophreniform disorder
Delusional disorder
Brief psychotic disorder
Shared psychotic disorder
Psychotic disorder NOS
Affective psychotic disorders
Bipolar I disorder with psychotic features
Major depressive disorder with psychotic features
Substance-induced psychotic disorder
Alcohol-induced psychotic disorder
Other substance-induced psychotic disorder
Psychotic disorder due to a general medical condition  
 
 
As the aetiology and pathogenesis of psychiatric disorders are largely unknown, the 
diagnostic classification is based on symptoms and sets of symptoms. At the 
beginning of the history of psychiatric nosology, the different definitions of 
psychotic disorder were based on the “great professor principle” (Kendler, 1990, 
2010). Most famous among these have been the descriptions by Kraepelin, Bleuler 
and Schneider, all of whom emphasized different aspects of the psychotic disorders. 
All of these authors have had their own impact on the subsequent psychiatric 
classifications, but the differentiation of the dementia praecox (later named as 
schizophrenia) and manic depression has formed the basis of the classification of 
psychoses over the last 100 years. The World Health Organization (WHO) first tried 
to develop a universal diagnostic system and the International Classification of 
Diseases (ICD-6) was published in 1948. The first version of the Diagnostic and 
Statistical Manual for Mental Disorders (DSM) was published in 1952. Soon after 
this, the first revisions ICD-8 and DSM-II were published (Tandon et al., 2009). 
However, the diagnostic practices were varying for decades. It was shown that in the 
1960s and 1970s American psychiatrists diagnosed schizophrenia more often than 
Review of the literature 
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British psychiatrists, who were more likely to diagnose affective disorders (Kramer, 
1969). The large variation in diagnostic practices promoted the development of the 
psychiatric nosology based on scientific knowledge (Kendler, 1990) and this 
research was very active in the 1980s and 1990s. The first operational diagnostic 
criteria such as Feighners Criteria (Feighner et al., 1972), the Research Diagnostic 
Criteria (Spizer et al., 1978), DSM-III (American Psychiatric Association, 1980) and 
DSM-III-Revised (American Psychiatric Association, 1987) were introduced earlier 
in the United States than in Europe (WHO, 1992). In fact, DSM-IV (American 
Psychiatric Association, 2000) and ICD-10 classifications of psychotic disorders are 
largely based on dividing endogenous psychoses into dementia praecox and manic 
depressive insanity proposed by Emil Kraepelin (1919). This dichotomy, currently 
called schizophrenia and bipolar disorder, is still today under continuous critical 
discussion. Already Kreapelin recognized that many patients present symptoms from 
both disorders, and this “in-between“ concept was later named as schizoaffective 
disorder (Kasanin, 1933). 
 
The diagnostic criteria of schizophrenia have been narrowed since the introduction 
of the DSM-III criteria (Andreasen et al., 1993, Andreasen, 1997). Concordance 
between diagnoses made using DSM-III and more recent criteria and those using 
more historical definitions are only modest (McGorry et al., 1992). At the same time 
the diagnostic criteria of affective disorders have been widened (Tohen and Angst, 
2002). Manic depressive and depressive disorders were separated from each other 
already in the ICD-8, and the diagnostic criteria for recurrent depressive disorder 
were introduced in the DSM-III and ICD-10. Depressive disorder with psychotic 
features was described in the DSM-III. 
 
The tenth edition of the International Classification of Diseases ICD-10 (WHO, 
1992) is most often used in clinical practice. Although the definitions of psychotic 
disorders in the current DSM-IV and ICD-10 classifications overlap to a great 
extent, there are still some differences. For example, in the diagnostic criteria of 
schizophrenia, ICD-10 gives slightly more weight to the Schneider’s first-rank 
symptoms: audible thoughts, voices arguing and/or discussing, commenting voices, 
somatic passivity experiences, thought withdrawal or broadcasting, delusional 
perception, made impulses, thoughts, or volitional acts (Carpenter et al., 1973), than 
the DSM-IV. The duration of illness is 6 months in the DSM-IV and 1 month in the 
ICD-10. The differentiation of schizophrenia, schizoaffective disorder and affective 
disorders also vary. The DSM-IV stresses poor outcome in schizophrenia, while this 
criteria is not included in the ICD-10. Both systems require exclusion of substance 
use and general medical condition. The concordance of the diagnostic systems 
seems to be higher in studies including subjects with long duration of illness 
(Pihlajamaa et al., 2008). 
Review of the literature 
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The aim the diagnostic classification is the diagnostic validity. Diagnostic validity is 
a complex construct, which First et al. (2004) listed as:  
 
• Face validity: Whether the diagnostic criteria seem to accurately describe the 
disorder. 
• Descriptive validity: Whether the diagnostic criteria specify a disorder uniquely 
relative to other disorders. 
• Predictive validity: Whether the diagnosis is predictive of future clinical course 
and outcome. 
• Construct validity: The extent to which the diagnosis correlates with external 
validators, such as neurobiological markers or genetic risk.  
 
Psychiatric diagnoses often lack construct validity (Jablensky et al., 2006, Zachar et 
al., 2007). For example, the risk of many psychotic disorders is elevated in same 
families, suggesting that they partly share a common genetic cause (Lichtenstein et 
al., 2009). Neuropsychological deficits occur in many psychotic disorders, but they 
may be more severe in schizophrenia (Lewandowski et al., 2011, Tuulio-Henriksson 
et al., 2011). Multifactorial aetiology of disorders makes it difficult to determine the 
construct validity (Kendler et al., 1980). Psychiatric diagnoses should also be helpful 
in clinical practice, i.e. have clinical utility. The clinical utility guides the choice of 
effective interventions and the prediction of future clinical management needs, and 
provides information on prognosis (First et al., 2004, Kendell and Jablensky, 2003). 
Predictive and descriptive validity of psychiatric diagnoses are among the most 
decisive factors in clinical utility.  
2.1.1 Description of specific psychotic disorders 
 
Schizophrenia  
Schizophrenia is one of the most common and severe psychotic disorders. In fact it 
is a cluster of disorders characterized by fundamental disturbances of thinking, 
perception and emotions. The onset of schizophrenia is often in young adulthood, 
and for those affected the disorder often causes many years of severe suffering. The 
course and symptoms in individual patients are highly variable, but for a smaller 
group the disorder causes lifelong disabilities with deterioration in functional 
capacity (Insel, 2010). A recent meta-analysis found a median proportion 13.5% 
(25%–75% quantiles 8.1%–20.0%) of recovery in schizophrenia (Jääskeläinen et al., 
2012). 
 
Diagnostic criteria of schizophrenia in the DSM-IV are presented in Table 2. Some 
signs of the disorder have to persist at least six months to permit the diagnosis. 
During this continuous period, at least two of the following symptoms should be 
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present for at least one month: delusions, hallucinations, disorganized speech, 
grossly disorganized or catatonic behaviour, or negative symptoms. Social and 
occupational dysfunction is an essential characteristic of schizophrenia (American 
Psychiatric Association, 2000).  
 
The subtypes of schizophrenia in the DSM-IV are paranoid, disorganized, catatonic,  
undifferentiated and residual types. The subtype diagnoses are hierarchic. Catatonic 
type is assigned if prominent catatonic symptoms are present regardless of other 
symptoms. In the absence of catatonic type, the disorganized type is assigned if 
disorganized speech and behaviour, and flat or inappropriate affect are present. In 
the absence of catatonic and disorganized type, the paranoid type is diagnosed if the 
person has prominent delusions or hallucinations and no or only mild negative and 
disorganized symptoms. Finally, undifferentiated type is assigned if none of the 
above mentioned criteria are fulfilled, but the symptoms fulfilling the diagnostic 
criteria of schizophrenia are present. Residual type is diagnosed when active-phase 
symptoms are no longer present, but there is continuing evidence for the disturbance 
(American Psychiatric Association, 2000).  
 
Schizophreniform disorder 
Schizophreniform disorder is basically identical with schizophrenia except that the 
duration of the disorder is at least one month, but full recovery in 6 months is 
required. Another difference is that decline in functioning is not required in 
diagnostic criteria of schizophreniform disorder, while decline in social and 
occupational function is one criteria of schizophrenia. The diagnosis is often 
provisional; if symptoms persist beyond six months, the diagnosis is changed to 
schizophrenia (American Psychiatric Association, 2000).  
 
Schizoaffective disorder 
In schizoaffective disorder, the full criteria of both the active phase of schizophrenia 
and a mood episode (major depressive episode, manic or mixed episode) should be 
met. During the same period of illness, there must be at least a 2 week period of 
delusions or hallucinations without prominent mood symptoms. Symptoms that meet 
criteria for a mood episode should be present for a substantial proportion of the total 
duration of the active and residual periods of the illness (American Psychiatric 
Association, 2000).  
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Table 2.  Diagnostic Criteria for Schizophrenia (DSM-IV-TR, American Psychiatric 
Association, 2000).                                                                                                                                                      
  
A. Characteristic symptoms: Two or more of the following symptoms should 
be present for a significant portion of time during a one-month period (or less if 
successfully treated): 
(1) Delusions 
(2) Hallucinations  
(3) Disorganized speech 
(4) Grossly disorganized or catatonic behavior 
(5) Negative symptoms 
 
Only one Criterion A symptom is required, if delusions are bizarre or 
hallucinations consist of a voice keeping up a running commentary on the 
person’s behavior or thoughts, or two or more voices conversing with each 
other. 
 
B. Social / occupational dysfunction: For a significant proportion of the time 
since the onset of the disturbance, one or more major areas of functioning such 
as work, interpersonal relations, or self-care are markedly below the level 
achieved prior to the onset (or if the onset is in childhood or adolescence, failure 
to achieve the expected level of functioning). 
 
C. Duration: Continuous signs of the disturbance persist for at least 6 months. 
This 6-month period must include at least 1 month of symptoms (or less if 
successfully treated) that meet Criterion A and may include periods of 
prodromal or residual symptoms. During these prodromal or residual periods, 
the signs of the disturbance may be manifested by only negative symptoms, or 
two or more symptoms listed in Criterion A in an attenuated form.  
 
D. Schizoaffective and mood disorder exclusion: Schizoaffective disorder and 
mood disorder with psychotic features have been ruled out because either 1) no 
major depressive, manic or mixed episodes have occurred concurrently with the 
active-phase symptoms; or 2) if mood episodes have occurred during active-
phase symptoms, their total duration has been brief relative to the duration of 
the active and residual periods. 
 
E. Substance / general medical condition exclusion: The disturbance is not 
due to the direct physiological effects of a substance or a general medical 
condition. 
 
F. Relationship to a pervasive developmental disorder: If there is a history of 
Autistic disorder of another pervasive developmental disorder, the additional 
diagnosis of schizophrenia is made only if prominent delusions or hallucinations 
are also present for at least a month (or less if successfully treated).  
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Delusional disorder 
Delusional disorder is characterized with one or more non-bizarre delusions 
persisting at least 1 month. Other prominent active-phase symptoms of 
schizophrenia should not be present, except that tactile and olfactory hallucinations 
may be present if they are related to the delusional theme. Apart from the impact of 
delusion or its ramifications, functioning is not markedly impaired and behaviour is 
not obviously odd or bizarre (American Psychiatric Association, 2000). 
 
Brief psychotic disorder 
Brief psychotic disorder is characterized by sudden onset of psychotic symptoms 
(delusions, hallucinations, disorganized speech, grossly disorganized or catatonic 
behaviour) which last at least one day or more, but no longer than one month. After 
this, a full remission and return to the premorbid level of functioning should be 
achieved (American Psychiatric Association, 2000).  
 
Bipolar I disorder  
Bipolar I disorder BPI is an affective type of psychosis, characterized with one or 
more manic or mixed episodes, usually accompanied with major depressive 
episodes. Psychotic symptoms, which have to be delusions or hallucinations, can 
occur during manic, mixed and severe depressive episodes. Typical mood-congruent 
psychotic symptoms during manic episoders include grandiosity and persecutory 
delusions linked to some special features of the person. Mood-incongruent psychotic 
symptoms include persecutory delusions without grandiose themes or delusions of 
thought insertion, thought broadcasting or being controlled.  
Bipolar II disorder diagnosis means that person has had at least one hypomanic, but 
no manic or mixed episodes, and one major depressive episode. Bipolar II disorder 
may also include psychotic symptoms during the severe depressive episodes. 
Bipolar I disorder leads to hospitalizations, need for treatment, and decline in daily 
functioning more often compared with bipolar II disorder (American Psychiatric 
Association 2000).  
 
Major depressive disorder with psychotic features  
Major depressive disorder with psychotic features is diagnosed when the criteria for 
major depressive disorder episode are met and delusions or hallucinations occur 
within the episode.  Mood-congruent delusions or hallucinations are consistent with 
the depressive themes (delusions of guilt, delusions of deserved punishment, 
nihilistic delusions etc.). Mood-incongruent delusions or hallucinations do not have 
any apparent relationship to depressive themes (persecutory delusions, delusions of 
thought insertion, delusions of control etc.) (American Psychiatric Association, 
2000). 
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Substance-induced psychotic disorder  
Substance-induced psychotic disorders are characterized by prominent 
hallucinations or delusions that are judged to be due to the direct physiological 
effects of a substance (drug of abuse, a medication, or a toxin exposure). Substance-
induced psychotic disorders are distinguished from the substance-induced delirium 
(clear consciousness), from substance intoxication or withdrawal with perceptual 
disturbances (more persistent, clinically relevant symptoms, and the person has no 
insight) and from primary psychotic disorders. The onset of substance use typically 
precedes the onset of psychotic symptoms, and the symptoms should disappear 
within one month after the substance use has ceased.  
 
Psychotic symptoms can occur during intoxication or withdrawal of the following 
classes of substances: alcohol, sedatives, hypnotics and anxiolytics, amphetamine, 
cannabis, cocaine, hallucinogens, inhalants, opioids, phencyclidine and related 
substances. Some medications can also evoke psychotic symptoms (for example 
antiparkinsonian medications, corticosteroids, anticholinergic agents, antimalarial 
medications and chemotherapeutic agents). The clinical picture of the psychotic 
disorder varies depending on the substance (American Psychiatric Association 
2000).  
  
Psychotic disorder due to a general medical condition 
Psychotic disorder due to a general medical condition is a category with the essential 
feature of prominent hallucinations or delusions. These symptoms can be judged to 
be due to the direct physiological effects of a general medical condition, and they 
are not explained by any other mental disorder. Clear temporal association should be 
found between the general medical condition and the onset of psychotic disturbance. 
Additionally, there must be literature evidence on the particular medical condition 
causing psychotic symptoms.  Examples of general medical conditions that can 
cause psychotic symptoms include temporal lobe epilepsy, brain lesions and 
tumours, central nervous system infections and any severe medical condition 
requiring treatment in intensive care unit (American Psychiatric Association, 2000).  
 
Other psychotic disorders 
Shared psychotic disorder is a rare condition where an individual develops a 
delusion in a close relationship with another person, who has an already established 
delusion. The content of the delusion is similar to that of the person who already has 
the established delusion (American Psychiatric Association, 2000). 
 
Delirium is a condition characterized by disturbance of consciousness and cognition 
which may have psychotic symptoms as an associated feature (American Psychiatric 
Association 2000). The aetiology of delirium varies, including substance-induced 
delirium and delirium due to a general medical condition. Despite the aetiology, the 
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disturbance develops over a short period of time, usually hours to days, and tends to 
fluctuate during the course of the day. 
 
Psychotic disorder NOS is a category, which is used when psychotic symptoms 
(delusions, hallucinations, disorganized speech, grossly disorganized or catatonic 
behaviour) occur, but a specific diagnosis of any psychotic disorder cannot be made. 
There may be inadequate information to make a specific diagnosis, the information 
is contradictory or symptoms do not meet full criteria for a specific psychotic 
disorder. The diagnosis is assigned for example if 1) a postpartum psychosis does 
not meet criteria for a specific psychotic disorder, 2) psychotic symptoms have 
lasted for less than 1 month but have not yet remitted, 3) persistent auditory 
hallucinations occur in the absence of any other psychotic feature, 4) persistent non-
bizarre delusions occur with periods of overlapping mood episodes that have been 
present for a substantial portion of the delusional disturbance, 5) there is uncertainty 
about whether psychotic symptoms are primary or due to substance use or general 
medical condition (American Psychiatric Association, 2000).  
2.1.2 Delusional disorder and subtypes of schizophrenia 
Some inter-diagnostic boundary issues in DSM-IV have received little attention, 
although these were discussed more during earlier stages of the DSM classification 
development. Two such examples are the diagnostic classification of psychoses with 
paranoid symptoms, i.e. between delusional disorder and paranoid schizophrenia, 
and the diagnostic validity of subtypes of schizophrenia.   
 
Paraphrenias were defined already by Kraepelin as an entity separate from the 
dichotomy of dementia praecox and manic depressive insanity. These paranoid 
disorders were characterized by delusions and hallucinations, no prominent 
disorders of emotion and volition, and well preserved mental activities (Kraepelin, 
1919). The nosological history of subtypes of schizophrenia is also long (Bleuler, 
1950, Kraepelin, 1919) for example, hebephrenia and catatonia are older concepts 
than schizophrenia itself (Bleuler, 1950).  
 
The validity of different definitions of psychoses with paranoid symptoms and 
schizophrenia subtypes was investigated actively during the formulation of the 
diagnostic operationalisations of DSM-III and DSM-III-R (Fenton & McGlashan, 
1991, Kendler et al., 1981, 1984, 1994, Kendler & Hays, 1981, Kendler & Tsuang, 
1981, McGlashan & Fenton, 1991). The diagnosis of delusional disorder was 
introduced in the DSM-III-R as a result of throughout nosological work (Kendler, 
1980, Kendler and Tsuang, 1981). The validity of the DSM-III-R delusional disorder 
criteria was investigated in the early 1990s (Fennig et al., 1996, Kendler and Walsh, 
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1995), but little attention has been paid to the validity of the revised DSM-IV 
criteria.  
 
Concurrent with the introduction of the criteria for delusional disorder, the criteria 
set in the DSM-III for different schizophrenia subtypes were modified for the DSM-
III-R. These criteria were refined further for the DSM-IV. Paranoid schizophrenia 
was narrower in the DSM-III-R compared with the DSM-IV. The DSM-III-R 
criteria required the presence of either systematized delusions or auditory 
hallucinations related to a single theme. The criteria of disorganized schizophrenia 
are, in contrast, narrower in the DSM-IV. This diagnosis requires that disorganized 
speech, disorganized behaviour, and flat or inappropriate affect should all be 
prominent (American Psychiatric Association, 1994), while only one of the two first 
mentioned symptoms were required in the DSM-III-R.   
 
In DSM-IV, prominent delusions are the core feature of both delusional disorder and 
paranoid schizophrenia. These disorders are differentiated by requiring that persons 
with delusional disorder may not have bizarre delusions or prominent hallucinations, 
and that their functioning should not be markedly impaired and behaviour obviously 
odd or bizarre - apart from the impact of delusion or its ramifications (American 
Psychiatric Association, 2000). Paranoid schizophrenia is characterized by 
preoccupation with one or more delusions or frequent auditory hallucinations, and 
by the absence of prominent thought disorder, disorganized or catatonic behaviour, 
and flat or inappropriate affect (American Psychiatric Association, 2000). 
Symptoms of schizophrenia must be present for at least six months, whereas only 
one month duration is required in delusional disorder (American Psychiatric 
Association, 2000). In practice, both disorders tend to last for years.  
 
Little attention has been paid to the validity of the current delusional disorder 
diagnosis and schizophrenia subtypes criteria, even though a small change in 
diagnostic criteria can have a large impact on the validity of the diagnosis (Kendler 
et al., 1994a, Kupfer et al., 2002). However, research has been active recently when 
DSM-V has been planned (Pillmann et al., 2012a,b, Wustmann et al., 2011, 2012). 
The prevalence and outcome of the disorders has varied according to the used 
criteria (Bogren et al., 2009, Kendler 1980, 1981, Kendler and Tsuang 1981, 
Leboyer et al., 1990). The age at onset of psychotic symptoms has been found to be 
higher and the outcome better in subjects affected with delusional disorder than with 
schizophrenia (Kendler 1980, 1982, Marneros et al., 2012), although contradictory 
results of the age of onset of delusional disorders come from some clinical samples 
(Hsiao et al., 1999, Maina et al., 2001, Opjordsmoen et al., 1991). However, 
diagnosis of delusional disorder may be inconsistent in the early phase of the illness 
(Fennig et al., 1996, Schwartz et al., 2000), but it seems to be stable during later 
phases (Marneros et al., 2012). Subjects with delusional disorder are less often 
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hospitalized, and for shorter periods compared with subjects with schizophrenia 
(Marneros et al., 2012). These findings support the need for longitudinally based 
diagnostic assessment, and need for more general population samples in addition to 
clinical studies.  
 
Results on the validity of delusional disorder as a separate disease from 
schizophrenia have been contradictory. Family studies have suggested that 
delusional disorder might not be genetically linked to schizophrenia (Howard et al., 
1997, Kendler et al., 1981, Kendler and Walsh 1995). However, patients with 
delusional disorder resemble patients with schizophrenia in many neurobiological 
features like having abnormalities in eye movements (Campana et al., 1998, 
Gambini et al., 1993), cognitive deficits (Evans et al., 1996, Hardoy et al., 2004) and 
brain structural abnormalities (Howard et al., 1994). Contrary with the original 
description of paranoia by Kraepelin (Kraepelin, 1919), marked depressive 
symptoms have been found to associate with delusional disorders in some studies 
based on clinical samples (Hsiao et al., 1999, Maina  et al., 2001, Serretti et al., 
1999). The aetiological relationship between delusional disorder and major 
depressive disorder has been suggested to be stronger than the connection between 
delusional disorder and schizophrenia (Howard et al., 1997). However, all studies 
have not found the association with depressive symptoms (Marneros et al., 2012). 
 
Subtypes of schizophrenia have not been included in the recent general population 
studies, and the knowledge of their occurrence is scarce. In previous studies, there 
has been more males than females in each subtype (Kendler et al., 1994a), although 
the results are contradictory (Fenton and McGlashan, 1991). Studies comparing the 
course and outcome of schizophrenia subtypes suggest that each subtype has 
distinctive course and outcome (Fenton and McGlashan, 1991, Kendler et al., 1984, 
1994, McGlashan and Fenton, 1991). The age at onset has been found to be 
youngest in disorganized subtype and oldest in paranoid subtype and outcome best 
in paranoid and worst in disorganized schizophrenia (Fenton and McGlashan, 1991, 
Kendler et al., 1984, 1994, McGlashan and Fenton, 1991). Course and outcome of 
undifferentiated schizophrenia has resembled disorganized schizophrenia more than 
paranoid schizophrenia in the studies using DSM-III and DSM-III-R criteria (Fenton 
and McGlashan 1991, Gruenberg et al., 1985, Kendler et al., 1984, 1994). No 
differences in the familial risk for schizophrenia between the subtypes have been 
found (Kendler et al., 1994b, Peralta and Cuesta, 2007).  
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2.2 Epidemiology of psychotic disorders  
Epidemiology means the study of the distribution and determinants of disease in 
human populations. The distributions of diseases are often studied by age, gender, 
region, social class, marital status, ethnicity and occupational status (Woodward, 
1999).  
 
Different measures of frequency are used in different settings and for different 
purposes when estimating the number of people in a community who have the 
studied disease. Incidence is the number of new cases of the disease within a 
specified period of time. It is expressed as the rate per person years. Cumulative 
incidence is the proportion of all people who develop the disease during a defined 
period. The denominator includes all people at risk for getting the disease, for 
example all persons in a certain birth cohort. Prevalence is the number of persons in 
a determined population who have a particular health condition at a time point or 
period. A period prevalence uses the same denominator as the time point prevalence, 
but it expands the numerator to include all cases present during a selected time 
period, like one month, six months, one year or lifetime. Lifetime prevalence allows 
individuals with chronic psychiatric conditions and temporarily in remission, to be 
included in prevalence counts. Thus, the lifetime prevalence of psychotic disorders 
is determined as the total number of cases now alive, presently of previously 
actively psychotic, divided by the size of the population studied (Tsuang and Tohen, 
2002, p. 6). The lifetime risk or lifetime morbid risk is a measure which reflects the 
risk of a disease up to certain age. It is the probability of having a disesase for a 
person who survives through the susceptibility period to manifest the disorder. The 
problem is that there does not seem to be an age after which the chance of 
developing the disease is 0, and the total lifetime risk is thus usually unknown 
(Thompson and Weissmen, 1981).  
 
Lifetime prevalence can be assessed in cross-sectional general population studies. It 
is a useful measure for example in service planning. Incidence is a better measure 
when causes of the disease are being investigated. The prevalence depends on the 
incidence, but it also depends on the duration of the disease and number of entries 
and exits in the studied population (for example births, deaths and migration). 
(Tsuang and Tohen 2002, p. 6) 
2.2.1 Population-based studies on psychotic disorders 
Most of the epidemiological studies of psychotic disorders have focused on 
schizophrenia and bipolar disorder. History of general population studies on 
psychotic disorders started with studies that relied on clinical diagnoses obtained 
from key informants, medical records or case registries (Jarvis, 1971, Faris and 
Dunham, 1939). However, diagnostic practices were varying and record-based 
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diagnoses were not necessarily a reliable source of information at the time. After the 
introduction of the first modern nosologic systems, the first structured interviewing 
methods were also introduced. Studies focused mainly on treated patients, and their 
attention was on representative sampling, use of structured diagnostic interviews and 
focus on first-admission patients (Jablensky et al., 1992). The next step of 
epidemiologic studies on psychoses were studies that combined modern community 
sampling techniques with structured interview approaches to case identification. The 
first large scale study of this type was the Epidemiologic Catchment Area ECA 
Study (Robins and Regier, 1991), in which lay interviewers administered the 
Diagnostic Interview Schedule DIS. However, it was noted that the diagnosis of 
schizophrenia obtained with these structured interviews was not congruent with 
psychiatrists’ classification (Helzer et al., 1985, Spengler and Wittchen, 1988). To 
provide more reliable and valid rate estimates of schizophrenia and other psychoses, 
two-stage procedures for case identification have since been used (Phillips et al., 
2009). Clinical re-interviews by telephone have been conducted with subjects who 
were screened for psychotic disorders with a structured interview administered by a 
lay interviewer, for example in the National Comorbidity Survey NCS (Kendler et 
al., 1996), the Netherlands Mental Health Survey and Incidence Study NEMESIS 
(van Os et al., 2001) and National Comorbidity Survey-Replication NCS-R (Kessler 
et al., 2005).  
 
Besides the modern two-stage procedures, general population studies have relied 
either on psychiatric hospital case notes or national registers. These studies produce 
estimates of the treated prevalence, which does not include the proportion of 
subjects without hospital treatment, estimated at up to 15%-25% of subjects with 
schizophrenia (Isohanni et al., 1997, Jörgensen et al., 2010, Scully et al., 2004, 
Youssef et al., 1999). Studies based on the national registers are dependent on the 
accuracy of the diagnoses and studies based on the case notes are dependent on the 
diagnostic quality. There are not many register- based studies which have been able 
to confirm register diagnoses of psychotic disorder with interviews and/or review of 
the case notes (Arajärvi et al., 2005, Bogren et al., 2009, Isohanni et al., 1997, 
Kieseppä et al., 2000, Pihlajamaa et al., 2008, Sellgren et al., 2011). However, in 
studies where hospital registers or case records have not been available, prevalence 
rates of psychotic disorders have tended to be lower (Kessler et al., 2005, Kendler et 
al., 1996, Van os et al., 2001), probably reflecting the multiple methodological 
challenges in case finding and ascertainment in the general population. National 
registers have notable strengths regarding e.g. statistical power and 
representativeness and they also enable studying rare disorders, in which the study 
samples otherwise have to be enormous in numbers. However, the validity of the 
registers, and careful examination of the possible sources of bias are of main 
importance when studying register information (Haukka et al., 2007, Haapea et al., 
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2008). National registers have been available only in the Nordic countries (Tsuang 
et al., 2011, s. 117).  
 
One problem inherent to identification of subjects with psychotic disorder in general 
population studies is that there is no established method for screening individuals 
with psychotic disorders in the general population. Methods that have been 
developed (Bebbington et al., 1995) are usually sensitive and specific, but their 
positive predictive value remains poor because of the the prevalence of psychosis is 
low in the general population (Bebbington et al., 1995). Structured interviews, such 
as Diagnostic Interview Schedule and different versions of Composite International 
Diagnostic Interview have been used for screening non-affective psychoses in  
previous large scale community surveys (Kessler and Ustün, 2004). The questions 
assessing psychotic symptoms in these interviews were designed to normalize 
reports about delusions and hallucinations in order to make the reporting of the 
symptoms easier. An undesired consequence was that such questions have produced 
many false positive cases due to misinterpretation of questions according to clinical 
re-interviews (Kendler et al., 1996, Kessler et al., 2005, Regeer et al., 2004). The 
number of false negatives, as well as the magnitude of non-response is extremely 
difficult to estimate in these studies (Jablensky, 2000, Kessler et al., 2005). 
 
Diagnostic procedures in recent general population studies have largely relied on the 
information from interviews. However, using only a single source of information 
seems to lead to a significant risk of missing symptoms (Eaton et al., 2007, Fanous 
et al., 2012). Studies that have used case notes in addition to semi-structured 
interviews have found more subjects having psychotic disorders compared to studies 
using only self-reported information (Bogren et al., 2009, Isohanni et al., 2001, 
Kendler et al., 1993, Lehtinen et al., 1990, McNaught et al., 1997, Östling et al., 
2002). Scandinavian studies have been pioneers in this approach (Larsson and 
Sjögren 1948, Lehtinen et al., 1990, Lehtinen et al., 1993). Altogether, the most 
reliable studies are studies that integrate information from different sources; national 
registers, semi-structured interviews, information from case records or other 
important sources (Bebbington et al., 2004, Bogren et al., 2009, Isohanni et al., 
2001, Jenkins et al., 1997, Saha et al., 2006).  
General population studies of bipolar I disorder have not usually used two-stage 
strategies (Merikangas et al., 2011) and the diagnoses have been based on CIDI 
interviews. Only a few studies have used multiple sources of information for 
diagnostic assessment (Bogren et al., 2009).  
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2.2.2 Prevalence of psychotic disorders 
Schizophrenia and bipolar I disorder are the most common psychotic disorders, and 
most of the epidemiological studies of psychotic disorders have focused on these, 
especially on schizophrenia. General population studies of other specific psychotic 
disorders have been scarce. The usual practice has been to report non-affective and 
affective psychotic disorders as groups in general population studies (Kendler et al., 
1996, Kessler et al., 2005, Kirkbride et al., 2006, Lehtinen et al., 1990, van Os et al., 
2001). Sometimes the group “other psychoses” has been used, variably including 
substance-induced psychotic disorders (Kirkbride et al., 2006) and psychoses related 
to general medical conditions or not (Lehtinen et al., 1990, 1993). Psychotic-like 
symptoms have been found to be over ten times more common compared with 
psychotic disorders in general population (Nuevo et al., 2012, van Os et al., 2001). 
 
In the recent general population studies of psychotic disorders using two-stage 
strategies, the lifetime prevalence (LTP) in non-affective disorders has varied from 
0.5% to 1.6% (Kendler et al., 1996, Kessler et al., 2005, van Os 2001), in 
schizophrenia from 0.12% to 1.3% (Bijl et al., 1998, Bland et al., 1988, Canino et 
al., 1987, Chen et al., 1993, Scully et al., 2004, Wittchen et al., 1992,  Robins et 
Regier 1991) and in affective psychoses from 0.4% to 1.14% (Lehtinen et al., 1990, 
van Os et al., 2001). 
 
Only few general population studies have been able to use register and case note 
data and have taken into account all psychotic disorders, or assessed specific 
psychotic disorders in the same study. The recent Lundby study (Bogren et al., 
2009) found a 50-year period prevalence of 4.2% and LTP 2.82% for all psychotic 
disorders. The 50-year period prevalence estimate included all subjects in the 
original study population cohort, also persons deceased before follow-up. This 
estimate is thus higher than the lifetime prevalence. The LTP represented cohort 
subjects alive at the 40-year follow-up. The 50-year period prevalence was 2.25% 
for non-affective psychotic disorders, 0.62% for affective psychoses (including BPI, 
bipolar II disorder and bipolar disorder NOS) and 1.35% for secondary psychoses or 
delirium. The LTPs were 1.38%, 0.42% and 1.02%, respectively (Bogren et al., 
2009). In the previous Finnish general population survey (Mini-Finland Survey, 
1978-1980), the lifetime prevalence for any psychotic disorder was found to be 
2.2%, for schizophrenia 1.3%, for affective psychoses 0.4% and for other psychoses 
0.5% (Lehtinen et al., 1990). Studies conducted among subjects in public treatment 
services have produced lower estimates (Jablensky 2000, Morgan et al., 2012). 
The British incidence study AESOP also studied a wide category of psychotic 
disorders and found the distribution of the new onset cases being 67% for non-
affective, 28% for affective and 5% for substance-induced psychoses (Kirkbride et 
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al., 2006). The magnitudes of the psychosis groups were similar in a meta-analysis 
of British incidence studies (Kirkbride et al., 2012).  
 
Although the general assumption of the lifetime prevalence of schizophrenia has 
been 1% throughout the world (Hirschfeld, 2001, Mueser & McGurk, 2004) , the 
median lifetime prevalence was found to be considerably lower, only 0.4% (10%-
90% quantiles 0.16-1.21) in a comprehensive systematic review of prevalence in 
schizophrenia (Saha et al., 2005). The systematic review included a large number of 
studies related to the prevalence of schizophrenia published between 1965–2002. 
Particularly the recent population-based surveys (Kessler et al., 2005, Van Os et al., 
2001, Kendler et al., 1996) have found considerably lower prevalence of 
schizophrenia than many older studies (Torrey, 1987, Lehtinen et al., 1990). These 
unconvincingly low prevalence estimates may be a result of several reasons. These 
could include narrowing of the diagnostic criteria of schizophrenia after the 
introduction of the DSM-III criteria (Andreasen et al., 1993, Andreasen, 1997), a 
true decline in the prevalence, but potentially also increasing problems in case-
finding and ascertainment (Jablensky, 1995). Survey response rates have declined 
steadily for the past decades (Kessler et al., 2005). At the same time people with 
psychotic disorders are less likely than others to participate in a mental health survey 
(Allgulander, 1989, Bland et al., 1988, Kessler et al., 1995, 2005, Haapea et al., 
2008). If the only source of information have been from personal interviews, false 
negative cases may have been generated due to inadequate probing or denial of prior 
psychotic symptoms (Helzer et al., 1985, Kendler et al., 1996, Kessler et al., 2005, 
Spengler et al., 1988). Supporting this, studies that have used information from 
hospital discharge registers or case notes have found higher prevalences (Lehtinen et 
al., 1990, Östling et al., 2002, Isohanni et al., 2001) compared with studies that have 
relied only on information from the interviews. The quality of studies, defined by 
different methodological features such as case ascertainment methods and method of 
diagnostic assignment have been found to be parallel with the reported 
schizophrenia prevalence estimates (Saha et al., 2005). 
 
The incidence of schizophrenia has been found to be higher in men compared with 
women (Aleman et al., 2003), with male/female ratio of 1.4 (10 and 90 percent 
quantiles 0.3-2.4) found in the recent systematic review (McGrath et al., 2004). 
Some studies including older subjects have found no gender differences (Bogren et 
al., 2009). However, the gender difference has not been reflected in prevalence 
studies of schizophrenia (Saha et al., 2005). Some of the discrepancy in the 
estimates could be explained by more severe negative (Salokangas et al., 2007) and 
disorganized symptoms (Sharma et al., 1999; DeLisi et al., 2001, Tang et al., 2007, 
Thorup el al., 2007), poorer outcome (Grossman et al., 2006, Lauronen et al., 2007), 
earlier onset (Häfner et al., 2003) and higher mortality (Heilä et al., 2005) in men. 
However, the reason for this paradox is not clear (McGrath et al., 2008).  
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Diagnosing schizoaffective disorder is complex, and it is rarely included in general 
population studies. In older studies, it has been often grouped together with 
schizophrenia (Hovatta et al., 1997, Lehtinen et al., 1990). The prevalence of 
schizoaffective disorder has conventionally been thought to be up to half of that of 
schizophrenia and higher in women compared with men (Bardenstein et al., 1990). 
However, in the few existing studies very low prevalence estimates around 0%-
0.11% have been found (Bogren et al., 2009, Cho et al., 2007, Scully et al., 2004). In 
service-based studies, one-year prevalence of 0.07% among adult population 
(Widerlöv, 1997) and 0.14% among population over 60 years old (Meesters et al., 
2012) have been found. Results of gender differences are contradictory, some 
finding no gender differences (Laursen et al., 2007, Meesters et al., 2012, Scully et 
al., 2004, Widerlöv, 1997) others suggesting that the disorder is more common in 
women than in men (Coryell et al., 1984). 
 
Psychotic disorders with brief duration were rare in the Lundby study. LTP for 
schizophreniform and brief psychotic disorders were 0% and 0.11%, respectively 
(Bogren et al., 2009). In cross-sectional general population studies, LTP estimates 
vary from 0.02 to 0.2 for schizophreniform disorder (Bland et al., 1988, Canino et 
al., 1987, Chen et al., 1993, Cho et al., 2007, Hwu et al., 1989, Oakley-Browne et 
al., 1989, Robins et al., 1984, Robins and Regier, 1991) and 0.9% for brief psychotic 
disorder (Cho et al., 2007). The diagnosis of acute psychoses changes to mainly 
schizophrenia and related disorders or affective disorders in about 60% of the new 
cases during the following 3-6 years (Castagnini et al., 2008, Singh et al., 2004), 
while about one third of the affected subjects functioned well after 7 years without 
medication (Pillmann et al., 2005). Differences in diagnostic practices make it 
difficult to compare the results between countries (Nugent et al., 2011).  
  
Delusional disorder has been rarely included in general population studies. The LTP 
estimate of 0.30% was found in the Lundby study (Bogren et al., 2009), while other 
studies have found estimates ranging from 0.02%-0.04% (Copeland et al., 1998, 
Kendler et al., 1982, Widerlöv, 1997). In two studies using CIDI as diagnostic 
instrument, the LTP has varied from 0% (Cho et al., 2007) to 0.67% (Hwu et al., 
1989). Recent clinical samples have produced low estimates (Maina et al., 2001).  
 
The data on epidemiology of bipolar I disorder has not been as extensive as on 
schizophrenia, but in the last decades the research has shown a welcome increase. In 
bipolar I disorder, like in schizophrenia, the lifetime prevalence used to be reported 
as approximately 1% (Merikangas et al., 2009). In a recent World Mental Health 
Survey of 11 different countries, a LTP of 0.6% (range 0.0-1.0%) was found 
(Merikangas et al., 2011). Other recent general population surveys have commonly 
found higher lifetime prevalence rates for BPI, but the range is wider from 0% to 
3.3% (Alhasnawi et al., 2009, Angst et al., 1998, Grant et al., 2005, Gureje et al., 
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2006, Jonas et al., 2003, Kessler et al., 1994, Merikangas et al., 2007, 2009, Pini et 
al., 2005, ten Have et al., 2002, Weissman et al., 1996) than in the World Mental 
Health Survey (Merikangas et al., 2011). As opposed to non-affective psychotic 
disorders, most recent studies have used fully structured interviews for diagnosing 
bipolar disorders (Ferrari et al., 2011). Studies using older versions of fully 
structured interviews have found LTPs of BPI twice as high as studies using other 
diagnostic instruments (Waraich et al., 2004), which may be due to false positive 
diagnoses produced by these interviews when compared with clinical diagnoses 
(Kessler et al., 1997, Regeer et al., 2004). Accordingly, comparably low LTP 0.34% 
for bipolar disorders was found in the recent Lundby study where multiple sources 
of lifetime information were used for diagnostic assessment (Bogren et al., 2009). In 
Ireland, LTP 0.26% was found (Scully et al., 2004). The most recent and advanced 
version of the CIDI, the WHO-CIDI 3.0, was used in the World Mental Health 
Survey. This instrument was found to be equally reliable at diagnosing bipolar 
disorders when compared with clinical interviews, such as the the Structured 
Clinical Interview for DSM (SCID) interview (Kessler et al., 2006, Merikangas et 
al., 2011). However, the reappraisal studies have been based on a small number of 
possible bipolar disorder cases, and evaluation of false negative cases is a major 
challenge. In addition to methodological issues hampering the interpretation of the 
results, the changes in diagnostic criteria (Angst et al., 2004, Regeer et al., 2004) 
may be one reason why many older studies have detected lower estimates for BPI 
(Angst et al., 1998, Lehtinen et al., 1990).  
 
Psychotic states of bipolar I disorder have rarely been reported separately, but they 
have been found to vary from 20% to around 70% of subjects with BPI (Suominen 
et al., 2009). Psychotic symptoms in mood disorders have been associated with 
poorer functioning, more severe symptomology, and a worse outcome and 
psychosocial functioning compared with mood disorders without psychotic 
symptoms (Canuso et al., 2008, Coryell et al., 2001, Goes et al., 2007, Keller et al., 
2007, Kempf et al., 2005, Matthews et al., 2009). In psychotic mood disorders 
delusions and hallucinations are the only symptoms included in the diagnostic 
criteria, while for example disorganized behaviour is not regarded psychotic (Hua et 
al., 2011). Men and women have similar prevalence of bipolar disorder (Grant et al., 
2005, Jonas et al., 2002, Merikangas et al., 2007, ten Have et al., 2002, Waraich et 
al., 2004), but the results are contradictory (Merikangas et al., 2011). There may be 
gender differences in clinical features and course of bipolar disorder (Suominen et 
al., 2009). In clinical cohorts, men have preponderance in BPI (Mantere et al., 2004) 
and bipolar disorder seems to be better recognized in men (Mantere et al., 2008, 
Viguera et al., 2001).  
 
MDD with psychotic features, like other characteristic specifiers of MDD, have 
rarely been included in general population studies of major depressive disorders. 
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The Lundby study found a lifetime prevalence of 0.28% for MDD with psychotic 
features (Bogren et al., 2009). In the Epidemiologic Catchment Area study, the 
lifetime prevalence was estimated at 0.6% (Johnson et al., 1991), and point 
prevalence estimate at 0.4% was found in a community survey conducted by 
telephone interview (Ohayon et al., 2002). Other studies have been conducted 
among psychiatric outpatients (Gaudiano et al., 2009) or in hospital samples 
(Coryell et al., 1984, Tohen et al., 2012) in which 5.3%-25% of patients with MDD 
have had delusions or hallucinations.   
 
Relatively little research has been conducted related to other psychotic conditions in 
community samples, particularly substance-induced psychotic disorders and 
psychotic disorders due to general medical conditions (Bogren et al., 2009).  
2.2.3 Occurrence of psychotic disorders in Finland  
In Finland there is a long tradition of epidemiological studies on the most severe 
mental disorders (Alanen, 1966, Kaila, 1942, 1966). Previous studies have found a 
considerably higher prevalence of schizophrenia in Finland than the median 
prevalence in the review by Saha et al. (2005). In the pioneer Finnish general 
population survey (Mini-Finland Survey, 1978-1980), the lifetime prevalence of any 
psychotic disorder was found to be 2.2% (schizophrenia 1.3%, affective psychoses 
0% and other psychoses 0.5%) in the age group of 30 years and over (Lehtinen et 
al., 1990). Register data and clinical examination were used for case ascertainment. 
Structured psychiatric interview (Present State Examination interview) and register 
information were used for diagnosing mental disorders. Case notes were included in 
the complicated cases (Lehtinen et al., 1991). In a more recent register-based study, 
the prevalence of schizophrenia, schizophreniform disorder and schizoaffective 
disorder together was 1.2% (Hovatta et al., 1997). In the Northern Finland 1966 
Birth Cohort study the cumulative incidence of psychoses has been estimated 
(Isohanni et al., 2001, Moilanen et al., 2010). By the age of 34, 111 of 
approximately 10 000 subjects had been diagnosed with schizophrenia, 26 with 
other non-affective psychoses and 19 with affective psychoses. The lifetime 
prevalence of psychotic disorders including the psychosis related to dementia, was 
2.9% in the UKKI (Uusikaupunki-Kemijärvi) study (Lehtinen et al., 1993).  
The prevalence and incidence of bipolar I disorder in previous Finnish studies has 
been low (Kieseppä et al., 2004, Räsänen et al., 1998, Sorvaniemi and Salokangas, 
2005, Veijola et al., 1996, Väisänen, 1975). The prevalence of affective psychoses in 
the Mini-Finland Survey was 0.4% (Lehtinen et al., 1991). Prevalence of psychotic 
depression has not been studied separately in Finland. In the Health 2000 Study, 
3.4% of those with major depression were estimated to have had a severe episode 
with psychotic features according to the CIDI interview (Pirkola et al., 2005).  
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Altogether, previous research suggests that the prevalence of schizophrenia is high 
and bipolar disorder is rare in Finland compared with several other countries. If 
these are true differences, it means that the future potential to identify risk and 
protective factors of these disorders could be exceptionally good in Finland. 
However, there has been debate on whether the observed prevalence differences are 
merely caused by diagnostic inaccuracy (Taiminen et al., 2001).  
2.2.4 Sociodemographic features in psychotic disorders  
Over-representation of psychotic disorders among lower socioeconomic groups is 
well established (Lehtinen et al., 1991, Isohanni et al., 2001, Miettunen et al., 2007, 
Morgan et al., 2012). The association of lower social class and psychoses has been 
an interest since the early 20th century (Faris and Dunham, 1939). Also in recent 
general population studies, non-affective psychotic disorders have been found to 
associate with low socioeconomic status: low education, low income levels, 
unemployment and being unmarried; never married, separated, widowed, or 
divorced (Kendler et al., 1996, Kessler et al., 2005, Miettunen et al., 2007, 
Honkonen et al., 2007). Many older studies of bipolar disorder have suggested that 
bipolar disorder is more common in upper socioeconomic classes (Winokur, 1969). 
However, recent epidemiological studies have found that bipolar disorder is 
associated with lower income and education, and with being divorced or 
unemployed (Grant et al., 2005, Jonas et al., 2003, Kessler et al., 1997, Merikangas 
et al., 2007). Even though bipolar disorder has been found to associate with personal 
low income levels (Grant et al., 2005, Merikangas et al., 2007) it may not be 
associated to family income (Merikangas et al., 2007). Overall, the socioeconomic 
difficulties seem to be less pronounced in affective psychoses compared with non-
affective group (Gureje et al., 2002, Waghorn et al., 2012). Presenting 
sociodemographic features of non-affective and other psychotic disorders from the 
same studies has been scarce.  
 
The question whether lower social class is a cause (causation hypothesis) of 
consequence (selection hypothesis) of psychotic disorders has not been resolved 
(March et al., 2008). Low social class could result from psychotic disorder by 
selection or drift, usually folded into a common category of selection. Selection is an 
intergenerational process by which individuals are selected into lower social 
positions before and during the prodromal phase of the disorder. Drift is an 
intragenerational process by which already affected persons occupy lower social 
positions (March et al., 2008). One Finnish study suggested association with higher, 
but not with lower social position of the parents in subjects with schizophrenia 
(Mäkikyrö et al., 1997).  
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Both current and chronic social deprivation act in cumulative way in increasing the 
risk of psychosis (Cantor-Graae, 2007, Morgan et al., 2008). The individuals 
experiencing several aspects of social deprivation, e.g. being unemployed, living 
alone, being single, having poor education or having no close friends are at 
particular risk (Morgan et al., 2008). This may apply for both non-affective and 
affective psychoses (Morgan et al., 2008), even though the associations with 
affective psychosis are less marked, and some studies have also found contradictory 
results (Jones et al., 1993).  
 
In most of the recent general population studies, populations have been selected 
from residential/household units. Persons living in institutions and homeless persons 
have not been included (Kendler et al., 1996). However, schizophrenia is well over-
represented in homeless compared with non-homeless subjects (Folsom and Jeste 
2002, Folsom et al., 2005, Foster et al., 2012, Teesson et al., 2004). In a systematic 
review the average prevalence of schizophrenia among the homeless was estimated 
at 11% (range 4%–16%, Folsom and Jeste, 2002). Even though institutionalization 
and homelessness are highly variable in different countries, also the prevalence, age, 
gender distribution and socioeconomic characteristics may have a larger than 
thought impact on the results (Ran et al., 2009).  
2.2.5 Geographic variation in psychotic disorders  
Geographic comparisons in the prevalence of schizophrenia have been of interest 
since the end of 19th century, with multiplied number of epidemiological studies 
since the 1950s. There is substantial variation in the incidence and prevalence of 
schizophrenia when considered worldwide (McGrath et al., 2004, 2008, Saha et al., 
2005), although the claim of evenly distributed incidence and lifetime throughout 
the world still persists in some literature (Mueser and McGurk, 2004, Hirschfeld, 
2001). In systematic reviews, the central 80% of the estimates of prevalence and 
incidence showed around 5-fold differences (McGrath et al., 2004, Saha et al., 
2005), while some older reviews have found up to 13-fold differences (Eaton, 1985, 
Goldner et al., 2002, Torrey, 1987) in the prevalence. In comparison, there are six- 
to nine-fold differences between countries in the prevalence of heart diseases, which 
is another disease entity with multifactorial aetiology (Thom et al., 1985). 
 
In addition to variation between countries, occurrence of schizophrenia varies within 
countries. Up to threefold differences in prevalence have been found between 
different parts of countries (Torrey and Bowler, 1990, Scully et al., 2004, Youssef et 
al., 1999). There are also population isolates with exceptionally low (Egeland and 
Hostetter, 1983, Chen et al., 1993, Nimgaonkar et al., 2000) and high prevalence of 
schizophrenia (Böök et al., 1978, DeLisi et al., 2001, Hovatta et al., 1997, Varilo 
and Peltonen, 2004).  
Review of the literature 
THL — Research 97 • 2013 38 Epidemiology of Psychotic Disorders 
 
Urban-rural differences in psychotic disorders  
Faris and Dunham showed already in the 1930s that rates of first hospital admission 
for schizophrenia were higher in the centre of the city than in the periphery (Faris 
and Dunham, 1939). Recently, urban-rural differences in schizophrenia have been 
actively studied (Krabbendam, 2005, Lederbogen et al., 2011, van Os, 2010, Vassos 
et al., 2012). It has been clearly shown that in many countries the risk of 
schizophrenia is about two times higher in persons born or raised in urban areas 
compared with rural areas (Harrison et al., 2003, Lewis et al., 1992, Marcelis et al., 
1998, Mortensen et al., 1999, Pedersen and Mortensen, 2001, Scully et al., 2004, 
Sundquist et al., 2004, Van Os et al., 2001, Vassos et al., 2012). Similar result have 
been found for other non-affective psychoses (Harrison et al., 2003, Kirkbride et al., 
2006, Laursen et al., 2007). A dose-response relation has been found in many 
studies: the higher the population density in the area, the higher the risk of 
schizophrenia (Van Os et al., 2001, Pedersen and Mortensen, 2001, March et al., 
2008). Residing in urban area around the onset of illness is also associated with 
higher risk for schizophrenia to some extent (Sundquist et al., 2004), but the urban 
place of birth (Marcelis et al., 1998) and being raised in urban areas (Pedersen and 
Mortensen, 2001) are even more relevant. The most significant associations of 
increased risk of schizophrenia related to urban environment have been found in 
large metropolitan areas among the western societies like Denmark, the Netherlands, 
Sweden, United Kingdom and USA (March et al., 2008, Kelly et al., 2010). 
Contrary to this, negative results have been found for example from Finland 
(Suvisaari et al., 1999), Italy (Thornicroft et al., 1993), China (Phillips et al., 2009) 
and Australia (Mcgrath et al., 2001). Although urban-rural differences in the 
occurrence of schizophrenia have been shown in incidence studies (McGrath et al., 
2004, Vassos et al., 2010) the association is not as clear in prevalence studies (Saha 
et al., 2005).   
 
It has been suggested that urban lifestyle itself does not increase the risk of 
psychotic disorders. Instead, it can be regarded as a proxy variable for factors that 
more directly contribute to risk for schizophrenia (Keshavan et al., 2011). These 
factors responsible for or mediating the risk are still unknown. Several aspects 
including both environmental and genetic factors have been hypothesized to be of 
importance. Family history of schizophrenia and other severe mental illness 
(Pedersen and Mortensen, 2001, Van Os et al., 2003, 2004) as well as different 
environmental risk factors affecting from prenatal stages of life (Freeman, 1994, 
Takei et al., al 1995, Cannon et al., 2001) have been studied. Toxic exposures, 
vitamin D deficiencey, nutrition, infections, stress, variety of sociocultural factors or 
artifacts of selective migration (Eaton et al., 2000, Freeman, 1994, Pedersen and 
Mortensen, 2006a,b, Selten et al., 2007) have been included among such factors. 
Obstetric complications or maternal education did not mediate the association 
between urban environment and psychosis in one study (Harrison et al., 2003).  
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Recent studies suggest that different area level determinants (Zammit et al., 2010) 
like social capital (Allardyce et al., 2005, Kirkbride el al., 2008) and social 
fragmentation (March et al., 2008) and deprivation are strongly linked to psychotic 
disorders within cities. Similar area related characteristics associate with admissions 
in schizophrenia also in rural areas (Losert et al., 2012). 
 
Prominent geographic or urban-rural variation differences do not exist in affective 
psychoses, especially in bipolar I disorder (Eaton et al., 2000, Kirkbride et al., 
2007a, Laursen et al., 2007, Lloyd et al., 2005, Marcelis et al., 1998, Mortensen et 
al., 2003, Laursen et al., 2007, Scully et al., 2004). However, in the recent World 
Mental Health Survey (Merikangas et al., 2011), the LPT of BPI varied from 0% to 
1.0% between different countries, while comparison with earlier studies is difficult 
due to differences in diagnostic methods and definitions (Waraich et al., 2004). 
Information on urban-rural differences in the occurrence of other psychotic disorders 
has been scarce.  
 
The classification of urbanization has varied across studies according to the study 
focus, for example higher population density can be linked to the higher risk for 
infections. However, the results have usually remained regardless of different 
definitions of the urban environment (Harrison et al., 2003). In Sweden and USA, in 
spite of a detected increased risk for schizophrenia and non-affective psychoses in 
urban areas compared with rural areas, the rates of non-affective psychoses have 
been highest in sparsely populated areas (Harrison et al., 2003, Torrey and Bowler, 
1997). Sparsely populated areas do not exist in many countries where urban-rural 
differences have been studied. 
 
One challenge in studying urban-rural differences is that these regions vary by 
natural, cultural and social characteristics even within Europe (Ballas et al., 2003). 
For example in the UK, people in rural areas have lower proportions of limiting 
long-term illnesses, have higher education and own their houses more often 
compared with people in the urban areas. The situation has been quite contradictory 
in Finland, where the rural parts of the country have been least developed (Palmgren 
et al., 1964, Vaarama et al., 2010). Thus, it is very likely that the risk attributable to 
“urban” environment varies significantly in different sociocultural settings. 
Consistently with this, possible mechanisms acting in different levels of the 
environmental structures and contributing to the risk of an individual have been 
studied (Zammit et al., 2010, March et al., 2008). Recent interest has particularly 
focused on social capital and social fragmentation (March et al., 2008).  
 
Social capital involves characteristics at the community level, such as 
connectedness, participation and positive support between individuals. Social capital 
can be regarded as a relational resource, which determines the quality of life, 
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including our well-being and good health (Shan et al., 2012). High level of social 
capital has been found to be inversely related to the incidence of psychoses even 
after adjusting for individual-level characteristics and neighbourhood deprivation 
(Kirkbride et al., 2007b, Lofors and Sundquist, 2007). Social fragmentation involves 
disorganization and instability among communities, characterized by social isolation 
and poor communication among the inhabitants (Faris and Dunham, 1939, Brown, 
2011). Social fragmentation is associated with urban life, particularly in inner cities, 
and it has been associated with an increased risk for schizophrenia (Allardyce et al., 
2005). In a Swedish multilevel study (Zammit et al., 2010) almost all of the variance 
in the risk for non-affective psychosis was explained by individual-level variation 
rather than by variation in schools or neighbourhood. The association between 
urbanicity and psychosis seemed to be a reflection of increased social fragmentation 
present within cities. The findings suggest that certain characteristics that define 
individuals as being different from most other people in their local environment may 
increase the risk for psychosis (March et al., 2008, Zammit et al., 2010).  
 
Geographic variation of psychotic disorders in Finland 
In Finland, regional variation in the prevalence of schizophrenia has been different 
from many other countries; for decades it has been more common in rural areas and 
showed marked regional variation (Hovatta et al., 1997, Lehtinen et al.,, 1990, 
Korkeila et al., 1998, Salokangas et al., 1987, Suominen et al., 1975, Suvisaari et al., 
1999). In the Mini Finland general population survey conducted in 1978-1980 
(Lehtinen et al., 1990), schizophrenia was found to be most frequent in the West, the 
East and the North and least frequent in south-western and southern Finland. The 
lifetime prevalence of primary psychotic disorders in the SouthWest, the South, the 
West, the East and the North were 1.8%, 1.8%, 2.4%, 3.1% and 3.0%, respectively. 
A register-based study (Hovatta et al., 1997) found even larger regional differences 
in the prevalences. One recent study found some evidence that urban birth may be 
emerging as a risk factor in Finland in those born after the year 1960. However, the 
size of the studied age group was small and they were followed only until the age of 
26 (Haukka et al., 2001).  
 
Finland has been different from many other Europian countries in the social and 
economic structure (Haukka et al., 2001). The least developed areas in Finland have 
been rural (Palmgren et al., 1964). Urbanization occurred in Finland much later than 
in many other European countries (Korkiasaari and Söderling, 2003) and the change 
was exceptionally rapid. At the same time, after World War II, fast change in 
economic structure occurred. The high incidence and prevalence of psychotic 
disorders in rural areas has been suggested to be caused both by isolated, genetically 
homogeneous sub-populations in which genes predisposing to schizophrenia have 
been enriched (Hovatta et al., 1997) and clustering of environmental risk factors 
predisposing to psychotic disorders in these areas (Haukka et al., 2001).   
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2.3 Alcohol-induced psychotic disorders 
Alcohol-induced psychotic disorders belong to the substance-induced psychotic 
disorders. Substance-induced psychotic disorders are an important group of 
psychotic disorders, but they are rarely included in epidemiological studies (Bogren 
et al., 2009, Kirkbride et al., 2006). Recent studies on substance-induced psychotic 
disorders have generally focused on psychoses induced by illicit drug use (Caton et 
al., 2005, Drake et al., 2011). However, alcohol has a central role in substance use 
disorders (Somers et al., 2004), as it is the most commonly used substance among 
persons with substance-induced psychotic disorder (Caton et al., 2005). Alcohol use 
disorders (AUDs) are common in all developed countries (WHO, 2004, 2011). 
Alcohol consumption is the world’s third largest risk factor for disease and disability 
(Mannelli and Pae, 2007, Room et al., 2005). It is a causal factor in 60 types of 
diseases and injuries and a component cause in 200 others. Almost 4% of all deaths 
worldwide are attributed to alcohol (WHO, 2011). 
 
In general population surveys, the lifetime prevalence for DSM-IV alcohol 
dependence has been around 5%-14% (Bijl et al., 1998, Hasin et al., 2007, Kessler et 
al., 1994, 2005, Pirkola et al., 2006) and lifetime prevalence of all alcohol use 
disorders up to 30.3% (Hasin et al., 2007). AUDs are more prevalent in men than 
women (Pirkola et al., 2005, Rehm et al., 2009). These disorders are associated with 
young age, being unmarried, low education, unemployment and low income (Hasin 
et al., 2007, Jacobi et al., 2004, Kessler et al., 2005, Pirkola et al., 2005). 
Comorbidity with other substance use disorders and with mood, anxiety and 
personality disorders is common (Hasin et al., 2007, Pirkola et al., 2005). Mean age 
of onset of alcohol dependence is about 22 years (Pirkola et al., 2006). Only a 
quarter of the subjects with alcohol dependence have sought help for these 
conditions, with higher proportions in women than in men (Hasin et al., 2007, 
Pirkola et al., 2006).   
 
In Finland, the use of alcohol has tripled during the last three decades (THL, 2012, 
WHO, 2011). Also, the number of subjects with alcohol-induced psychoses tends to 
increase when the use of alcohol increases in the population (Cohen and Johnson, 
1988). In Finland, the LTP of alcohol dependence is 7.9% (Pirkola et al., 2006) for 
those aged 30 years and over and 5.6% for young adults (Latvala et al., 2009). 
Alcohol use disorders are also the most common substance-related disorders in 
Finland (Aalto-Setälä et al., 2001, Latvala et al., 2009). Substance use in Finland has 
been characterized by high level of drinking to intoxication and fairly low level of 
use of substances other than alcohol (Mäkelä et al., 2012, WHO, 2011).  
 
In general population studies, subjects with alcohol dependence have had an almost 
twofold risk for psychotic symptoms compared with those without dependence 
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independently of many other risk factors, including drug dependence (Degenhardt et 
al., 2001, Johns et al., 2004). There is no consensus about the possible aetiological 
role of alcohol in schizophrenia (Mueser et al., 1998, Glass, 1989a, Soyka, 1990,). 
 
Psychotic symptoms can occur in several clinical conditions related to alcohol: 
intoxication, withdrawal, alcohol-induced psychotic disorder or delirium, Wernicke-
Korsakoff syndrome and alcohol-induced persisting dementia (Greenberg and Lee, 
2001). Alcohol-induced psychotic disorder is usually preceded by heavy and long-
lasting alcohol consumption (Achte et al., 1969, Glass, 1989a, Lehtonen, 1996) 
indicating an alcohol use disorder. AUDs comprise alcohol dependence and alcohol 
abuse in the DSM-IV and of dependence or harmful use in the ICD-10. Alcohol 
dependence is not a necessary feature for diagnosing alcohol-induced psychotic 
disorder, but usually at least diagnosis of alcohol abuse can be assigned to an 
affected person (American Psychiatric Association, 2000). 
 
In DSM-IV, alcohol-induced psychotic disorders are characterized by an acute onset 
of hallucinations and/or delusions that occur either during or after a period of heavy 
alcohol consumption. Psychotic symptoms should be in excess of those usually 
associated with intoxication or withdrawal syndrome with perceptual disturbances, 
and symptoms should not persist more than a month during a substance free period. 
Alcohol withdrawal with perceptual disturbances is diagnosed instead of alcohol-
induced psychotic disorder if hallucinations occur with intact reality testing, which 
criterion has been criticized (Mathias et al., 2008). Alcohol-induced delirium is a 
disturbance of consciousness which may also present with psychotic symptoms as 
associated features (American Psychiatric Association, 2000).  
2.3.1 Epidemiology of alcohol-induced psychotic disorders 
Epidemiological studies on the prevalence of alcohol-induced psychotic disorder 
and delirium are scarce (Mattisson et al., 2011). Previous information on alcohol-
induced psychotic disorder and delirium is based on hospital samples, such as first-
episode psychotic patients in mental hospitals or on patients in alcohol treatment 
units (Achte et al., 1969, Lehtonen, 1996, Schuckit et al., 1995, Soyka, 2008a,b 
Tjuang et al., 1994, Victor and Adams, 1953). The annual prevalences of alcohol-
induced psychotic disorders (Soyka, 2008a) and alcohol-induced delirium (Soyka, 
2008b) have been 0.6%–0.7% and 4.9%–7.4%, respectively, in patients with alcohol 
dependence who were treated in psychiatric hospitals in Germany. In other clinical 
studies from substance abuse services, it has been estimated that 2%–7% of patients 
with alcohol dependence have had alcohol-induced psychotic disorders with 
hallucinations (Tsuang et al., 1994, Victor and Adams, 1953), 5%–11% have had 
delirium tremens (Eyer et al., 2011, Glass, 1989b, Greenberg and Lee, 2001, 
Hemmingsen et al., 1979, Schuckit et al., 1993, 1995) and one quarter have 
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experienced psychotic symptoms in their lifetime (Tsuang et al., 1994). Delirium is 
a life threatening condition which should be intensively treated. The mortality has 
been up to 15% in older studies (Mayo-Smith et al., 2004). Alcohol-induced 
psychotic disorder is acutely a milder form of alcohol withdrawal compared with 
delirium, but it is also related with increased long-term mortality (Glass, 1989b, 
Lehtonen, 1996).  
 
In first-episode psychosis studies, 5%-8.4% of the patients have had a substance-
related psychosis (Cantwell et al., 1999, Kirkbride et al., 2006, Singh et al., 2004), 
and 1.3% pure alcohol-related psychoses (Singh et al., 2004). Of the first-episode 
patients with substance induced psychotic disorder, 15% to 17 % have had an 
alcohol-related psychotic disorder (Caton et al., 2005, Singh et al., 2004), and 
further 40% have used two or more substances, with alcohol commonly being 
involved (Caton et al., 2005).  
 
In clinical samples of patients with alcohol dependence, those with alcohol-induced 
psychosis have had more severe dependence, earlier onset age of alcohol problems, 
higher consumption of alcohol per occasion, more alcohol-related life problems, and 
more drug use than those without psychosis (Achte et al., 1969, Lehtonen 1996, 
Tsuang et al., 1994). Subjects with delirium tremens are more likely to be male, 
older, less educated and separated/widowed (Schuckit et al., 1995). Also binge 
drinking, several earlier withdrawal episodes, use of illicit sedative-hypnotics, and a 
greater number of medical problems and psychiatric symptoms have been associated 
with a history of psychoses and delirium (Schuckit et al., 1995). Moderate or severe 
brain injury may increase the risk of delayed psychotic disorders (Achte et al., 1969, 
Hesdorffer et al., 2009, Koponen et al., 2002). 
 
The validity of substance-induced psychotic disorders has been challenged by the 
finding that half of the subjects with cannabis-induced psychosis later develop 
schizophrenia spectrum disorder (Arendt et al., 2005). Familial predisposition to 
psychiatric disorders and psychotic disorders contribute equally to the risk of 
developing schizophrenia or cannabis-induced psychosis (Arendt et al., 2008), but it 
has no effect on the later risk of schizophrenia spectrum disorder after developed 
cannabis-induced psychosis. Familial loading of schizophrenia is associated with 
developing psychosis also among methamphetamine users (Chen et al., 2005). 
 
Alcohol use disorders are associated with increased mortality (Hiroeh et al., 2001, 
Markkula et al., 2012, Poikolainen et al., 2011, WHO, 2011). Alcohol-related 
psychotic disorder (Moos et al., 1994) and delirium tremens among alcohol use 
disorder patients admitted to psychiatric treatment (Lewis et al., 1995) have been 
associated with high mortality compared with other subjects with alcohol or 
substance use disorders at follow-up. This is supported by recent findings in a 
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general population sample (Mattisson et al., 2011). Mortality associated with 
delirium has been found to be especially high in older studies, while the outcome of 
alcohol-induced psychosis has been found to be better (Lindelius et al., 1974, 
Lindelius and Salum 1972). In a Finnish study, 44% mortality was found for both 
groups during a 10 to 15 year follow-up (Lehtonen, 1996). 
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3 Aims of the Study  
The main objective of this study is to report the lifetime prevalences of 
specific/different psychotic disorders according to DSM-IV in the adult population 
of Finland. In addition, the purpose is to examine sociodemographic features and 
geographic variation in psychotic disorders in the general population and study 
clinical features of some psychotic disorders in more detail. 
  
The specific aims of this study are: 
• to obtain estimates of lifetime prevalence of all specific DSM-IV psychotic 
disorders in the general population by using multiple sources of information and 
to compare different screening methods for detecting psychotic disorders in 
general population studies (Study I). 
 
• to explore sociodemographic correlates and geographic variation of psychotic 
disorders in the Finnish adult population. Geographic variation is investigated 
both in terms of urban-rural differences and large area variation according to 
place of birth and place of residence (Study II). 
 
• to study epidemiology, clinical features, morbidity and mortality of alcohol-
induced psychotic disorder and delirium in more detail (Study III).   
 
• to provide epidemiological and clinical data (age at onset, symptoms, outcome 
and treatment) on delusional disorder and schizophrenia subtypes and to 
investigate the descriptive and predictive validity of delusional disorder and 
different subtypes of schizophrenia in the DSM-IV (Study IV).  
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4 Methods 
4.1 The Study design and subjects  
4.1.1 Health 2000 Survey 
This study forms part of the Health 2000 Survey, a national health examination 
survey (Aromaa and Koskinen, 2004). The main aim of the Health 2000 Survey was 
to provide an up-to-date comprehensive picture of health and functional ability of 
working age adults aged 30 years or over in the Finnish population. The major 
responsibility for project planning and implementation was carried out by the 
National Public Health Institute (KTL; since January 1st 2009 the National Institute 
for Health and Welfare, THL). Other agencies involved were the Finnish Centre for 
Pensions, the Social Insurance Institution of Finland, the Local Government 
Pensions Institution, the National Research and Development Centre for Welfare 
and Health, the Finnish Dental Association and the Finnish Dental Society, Statistics 
Finland, the Finnish Institute of Occupational Health, the Finnish Work 
Environment Fund, the UKK Institute for Health Promotion Research and the 
Occupational Safety and Health Fund of the State sector (Heistaro, 2008).  
 
The Health 2000 Survey population 
The Health 2000 Survey was based on a nationally representative two-stage 
stratified cluster sample of 8028 persons. The sampling design was developed by 
Statistics Finland’s experts and the research team in the National Public Health 
Institute (Heistaro, 2008). The sampling frame comprised adults aged 30 years and 
over living in mainland Finland and was regionally stratified according to the five 
university hospital regions. From each of them, 16 health care districts were sampled 
as clusters (altogether 80 health care districts in the whole country, including 160 
municipalities). The 15 largest towns in the country were all selected in the sample 
and the remaining 65 areas were selected by systematic probability proportional to 
population size PPS sampling in each stratum. These 80 areas were the primary 
sampling units. The ultimate sampling units, i.e. target persons, were selected by 
systematic sampling from the areas. No exclusion criteria were used in the sampling, 
e.g. institutionalized and homeless persons were included. Subjects 80 years of age 
or over were oversampled (2:1) in relation to their proportion in the population 
within the clusters to ensure adequate coverage of the oldest participants. (Heistaro, 
2008)  
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The field work was carried out between September 2000 and June 2001, and 
consisted of:  
• an interview at home (duration: 70-90 minutes). 
• a health examination in the local health care centre (duration: 3-4 hours). 
• a condensed interview and a health examination at home (or institution) for those 
unable to attend in the health care centre. 
• a telephone interview or a mail questionnaire for remaining subjects. 
 
Altogether, a total of 7419 subjects (93% of the 7977 subjects who were alive on the 
day they were contacted for the first phase of the survey) attended at least one study 
phase (Aromaa and Koskinen, 2004). Register information was also gathered on the 
whole sample both to complement baseline information and for follow-up purposes. 
Details of the sampling design and selection processes, as well as data collection for 
the Health 2000 Survey are described elsewhere (Aromaa and Koskinen, 2004, 
Heistaro, 2008, Laiho and Nieminen, 2004).  
 
Assessment of mental disorders in the Health 2000 Survey 
In the health examination, the physician assessed whether the subject had a definite 
or probable psychotic disorder. Mental disorders were also assessed in several other 
questionnaires and primarily by the Finnish translation of the Munich version of the 
Composite International Diagnostic Interview M-CIDI (Wittchen et al., 1998). The 
M-CIDI is a computerized, fully structured interview. The Finnish version covered 
12-month diagnoses of mood, anxiety, psychotic and substance use disorders, as 
well as lifetime diagnoses of alcohol and other substance dependence (Pirkola et al., 
2005). However, diagnoses of psychoses and bipolar disorder obtained using the 
CIDI have a poor level of agreement with clinical diagnoses, i.e. poor validity 
(Kendler el al 1996, Kessler et al., 2005, Regeer et al., 2004). Therefore, a second 
phase study called Psychoses in Finland PIF was conducted. The ethics committees 
of the National Public Health Institute and the Hospital District of Helsinki and 
Uusimaa approved the Health 2000 Survey (407/E3/2000) and the PIF reassessment 
(644/E3/2001). Participants provided written informed consent.  
4.1.2 The Psychoses in Finland Study 
The design of the PIF Survey is briefly introduced in Figure 1. First, the Health 2000 
sample was screened for possible psychotic disorders, and second a detailed face-to- 
face interview using the Structured Clinical Interview for DSM-IV, SCID-I (First et 
al., 2001) was conducted to those with a suspected psychotic disorder and to a 
random sample of controls. In addition to the interview, case notes from lifetime 
treatments for psychiatric problems were collected and also for those who did not 
participate in the interview. The final best-estimate diagnoses were based on 
systematic evaluation of the interview and the case note data.   
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Figure 1. Design of the Psychoses in Finland Study.                               
Abbreviations: PIF, Psychoses in Finland; SCID-I, Structured Clinical 
Interview for DSM-IV. 
4.1.3 Screening of psychotic disorders 
Individuals were selected for the re-interview using a psychosis screen (PIF screen) 
specifically designed for this survey (Figure 2). Psychosis screen consisted of 
several screens constructed from elements of the Health 2000 health examination, 
including the CIDI interview and register data. If any individual screen (A-C below) 
was positive, the person was invited for the re-interview.  
Health 2000 Survey 
Two-stage cluster sample of 8028 persons  
Population selected by the PIF screen 
N=746 
SCID-I interview 
N=444 
Final best-estimate diagnoses 
N= 692 
Contacted,  not interviewed  N=270 
(died N=46, declined N= 123,  
poor health  N=46, language problems N=7,  
not reached N=48) 
 
Declined in the Health 2000 , not contacted 
N=32 
 
Case notes N=248 No case notes found N=22 
Case notes were collected if  
mental health care contact was found  
N=248 
No case notes N=196  
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Figure 2. Number of Persons Selected by Specific Parts of the Psychosis Screen. 
One Person May be Selected by Several Screens.                   
Abbreviations: CIDI, Composite International Diagnostic Interview;  PIF, 
Psychoses in Finland.  
A. HEALTH 2000 –interview or the health examination: 
(1) Self-reported psychotic disorder: Subject reported having been diagnosed with a 
psychotic disorder in the mental health treatment questions of the home interview, 
telephone interview or mail questionnaire (N=77). 
(2) Psychotic disorder assessed by physician: Possible or definite psychotic disorder 
as assessed by the physician who conducted the health examination (possible N=17, 
definite N=28). 
 
B. CIDI INTERVIEW:  
In all sections of CIDI, subjects who reported that their symptoms had been caused 
by injury, physical illness, medication or substance abuse were also included. 
(1) Section F screen for bipolar I disorder: A lifetime episode of elevated and/or 
irritable mood lasting at least four days was reported by 360 subjects. After this, 
there are 12 questions about manic symptoms in the CIDI. These questions cover the 
seven DSM-IV manic symptoms, but some symptoms are asked with two or three 
separate questions. If the subject answered yes to any three of these 12 CIDI 
questions, the mania screen was positive. Additionally, the index symptoms were 
not required to occur at the same time as the elevated/irritable mood in this study 
(N=124). 
(2) Section G screen for lifetime positive psychotic symptoms: The symptom 
questions in the CIDI G section are presented in the Supplement 1. If any of these 
symptoms were scored positive (N=689), several questions concerning their clinical 
relevance, i.e. whether the symptom had interfered with normal life or whether the 
Popula'on	  selected	  by	  the	  PIF	  screen	  
N=746	  
Health	  2000	  Survey	  
8028	  persons	  	  
Baseline	  study	  	  
N=453	  
Medica7on	  
	  Reimbursement	  
	  Register	  	  
N=180	  
Na7onal	  Hospital	  	  
Discharge	  Register	  	  
N=238	  
Pension	  	  
Register	  	  
N=211	  
Prescrip7on	  	  
Register	  	  
N=36	  
Self-­‐reported	  
psychosis	  
N=77	  
Psychosis	  
assessed	  by	  	  
physician	  
N=45	  
CIDI	  
interview	  
N=404	  
Na'onal	  Registers	  
N=419	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person had talked about it with a health care professional, was asked. All subjects 
with any clinically relevant positive psychotic-like symptoms were considered 
screen-positives. In addition, all subjects reporting three or more psychotic-like 
symptoms regardless of clinical relevance were included (N=238).  
(3) Section P screen for formal thought disorder, negative and catatonic symptoms: 
In the section P, the interviewer assessed the presence of symptoms of positive 
formal thought disorder, negative symptoms, behaviour suggesting that the person 
had either hallucinations or catatonic symptoms. The screen for these symptoms 
consisted of having any of these symptoms except for slowed speech, which was too 
common to be used as a screen (N=93). 
(4) Remarks section of the CIDI interview, and the screen for odd behaviour: The 
interviewer noted remarks concerning the individual and the interview. If the subject 
was not selected by any of the other screens, but these remarks were indicative of 
psychotic disorder, the individual was selected for the re-interview (N=4). 
 
C. REGISTERS: 
(1) National Hospital Discharge Register: Hospital treatment  with a diagnosis of 
any psychotic or bipolar disorder according to the National Hospital Discharge 
Register between 1969 and 2002 (N=238).  
(2) Free Medication Register: Free medication for "Severe psychotic and other 
severe mental disorders" according to the Free Medication Register of the Finnish 
Social Insurance Institution (N=211). 
(3) Pension Register: Disability pension (permanent or temporary) because of any 
psychotic disorder, bipolar disorder or major depressive disorder according to the 
Pension Register of the Finnish Centre for Pensions (N=180). 
(4) The Finnish National Prescription Register: For screening bipolar I disorder the 
Finnish National Prescription Register of the National Insurance Institution was 
additionally used. All subjects not selected by any other screen who had used 
lithium, carbamazepine, oxcarbazepine, valproic acid, lamotrigine, gabapentin or 
topiramate between 1996-2002 without a self-reported or register diagnosis of 
epilepsy or any neurological or other somatic disorder which would account for the 
medication, were identified and selected for the re-interview (N=36).  
 
Registers 
The Finnish National Hospital Discharge Register has been computerized since 1968 
and covers all public and private hospitals, inpatient wards of local health centres, 
military wards and prison hospitals. The Hospital Discharge Register contains 
personal identification numbers, hospital identification codes, admission and 
discharge dates for each inpatient and daypatient stay, primary diagnosis and up to 
three subsidiary diagnoses. The discharge diagnoses are made by the attending 
physician. The accuracy of the data in the Finnish National Hospital Discharge 
Register has been found to be excellent (Keskimäki and Aro, 1991, Pajunen et al., 
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2005). The reliability of schizophrenia and schizophrenia spectrum disorders in the 
Finnish National Hospital Discharge Register has been assessed in several studies, 
and it has been found to be generally good (Arajärvi et al., 2005, Isohanni et al., 
1997, Kampman et al., 2004, Mäkikyrö et al., 1998, Moilanen et al., 2003, 
Pihlajamaa et al., 2008, Taiminen et al., 2001). This means that when clinicians do 
diagnose schizophrenia, it is usually congruent with the research diagnoses. 
However, clinicians tend to underdiagnose schizophrenia (Isohanni et al., 1997) and 
up to 50% of cases with a research diagnosis of schizophrenia have a register 
diagnosis of other psychotic disorder (Isohanni et al., 1997, Moilanen et al., 2003). 
Validity of the Finnish register diagnoses of schizophrenia have improved after 1982 
when the Finnish translation of the DSM-III was published (Pihlajamaa et al., 2008). 
 
Bipolar I disorder is underdiagnosed in clinical practice, too (Mantere et al., 2008). 
The existing diagnoses in the Finnish National Hospital Discharge Register had 92% 
accuracy for both diagnoses of bipolar I disorder and the manic type of 
schizoaffective disorder compared with research diagnoses (Kieseppä et al., 2000). 
In a first-episode sample, the agreement of clinician and research diagnoses was 
lower, kappa value being of 0.64 for bipolar I disorder, and 0.49 for psychotic 
depression (Taiminen et al., 2001). Subjects, who have had both bipolar I disorder 
and schizophrenia diagnoses in the register have been found to be a heterogeneous 
group (Laursen et al., 2005, Munk-Jörgensen, 1992). Of subjects with both 
diagnoses in the register, 43% received schizophrenia or schizoaffective disorder 
diagnosis according to DSM-IV criteria (Pihlajamaa et al., 2008). Validity of other 
psychosis diagnoses in the hospital discharge register has not been studied as 
intensively.  
 
The Pension register includes beginning and ending dates and the primary diagnoses 
for all permanent or disability pensions. The Free Medicine Register includes the 
diagnoses of persons entitled to free outpatient medication and the beginning dates. 
All persons residing permanently in Finland are entitled to medication 
reimbursement. Medications for severe and long-term diseases, including all 
psychotic and bipolar I disorders are fully reimbursed. The information in the 
Pension and Free Medicine Registers should be accurate as payments of the benefits 
are based on the registers.  
 
The Finnish National Prescription Register covers all pharmacies in Finland and 
records all reimbursed purchases of drugs in Finland for which the Social Insurance 
Institution has paid any reimbursement. The reimbursement system covers all 
permanent residents in the country. At the time of the study, reimbursement used to 
be paid in Finland only if the total purchase price exceeded a certain sum (8.41 
Euros in 2002) and thus low price medicines, like some older, generic medicines 
were not registered. Register contains information for example of the date of 
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purchase, the classification of medicines according to the Anatomic Therapeutic 
Chemical (ATC) classification system (WHO, 1994) and the dose of medicine stated 
as the international standard daily defined dose (DDD). The agreement between self-
reported medication and medication data obtained from the prescription register has 
been found to be generally good (Haukka et al., 2007, Haapea et al., 2010), the 
agreement being best for lithium (Cohen’s kappa 0.96) and antipsychotics (Cohen’s 
kappa 0.77-0.87), and good also for other mood stabilizers (Cohen’s kappa 0.84-
0.74) (Haukka et al., 2007, Haapea et al., 2010).   
 
Information on psychotic disorders was obtained from each register from 1969 up to 
December 2002, except from The Finnish National Prescription Register from 1st 
January 1996 to December 2002. The National Hospital Discharge Register records 
all five digits of diagnostic codes, allowing accurate identification of subjects with a 
diagnosis of psychotic disorder. In contrast, the Pension and the Free Medication 
registers recorded earlier only the first three digits, which means that MDD with and 
without psychotic disorders cannot be separated. It was decided to invite all subjects 
with a diagnosis of MDD from these two registers to ensure that all affective 
psychoses in these registers would be covered.  
 
The diagnoses in the registers were coded according to the ICD-8 before the year 
1987, from then until 1995, according to the ICD-9 using DSM-III-R criteria 
(Kuoppasalmi et al., 1989) and according to the ICD-10 since 1996. The five digits 
of the diagnostic codes in the National Hospital Discharge Register were included as 
presented in Table 3. 
 
Subjects selected only by the Hospital Discharge Register screening were contacted 
through the person responsible for the treatment and the case notes were sought with 
the approval of Finnish Ministry of Social Affairs and Health, excluding the subjects 
who had actively declined to participate in the Health 2000 Survey. Subjects 
selected only by other registers were contacted through the institutions in question. 
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Table 3.  The Diagnostic Codes Included from the National Hospital Discharge 
Register in Screening Psychotic Disorders 
Diagnosis Diagnostic classification Years Codes
Schizophrenia ICD-10 1996-2002 F20
ICD-8 and ICD-9 1969-1995 295.0-295.3, 295.5,
295.6, 295.8, 295.9
Schizoaffective disorder ICD-10 1996-2002 F25
ICD-8 and ICD-9 1969-1995 295.7
Other non-affective ICD-10 1996-2002 F22, F23, F24, 
psychotic disorders F28, F29
ICD-8 and ICD-9 1969-1995 295.4, 297, 298, 299
Bipolar disorder or ICD-10 1996-2002 F30, F31
manic episode ICD-9 1987-1995 2962-2967
ICD-8 1969-1987 2961, 2963
Major depressive disorder ICD-10 1996-2002 F32.3, F33.3
with psychotic features ICD-9 1987-1995 2961E
Psychotic disorder due to ICD-10 1996-2002 F03.X1, F03.X2, F05,
to a general medical F06.0, F06.1, F06.2, F06.31
condition ICD-9 1987-1995 293, 294
ICD-8 1969-1987 292-294 (except 294.3)
Substance-induced ICD-10 1996-2002 F1X.4, F1X.5, F1X.7
psychotic disorders ICD-9 1987-1995 291.0, 291.3, 291.8, 
292.1, 292.8
ICD-8 1969-1987 291.0, 291.2, 291.3, 
291.9, 294.3
 
4.1.4 Mental health assessment 
The screen-positive subjects were invited to a re-interview which were conducted 
between the years 2002 and 2004 (Figure 1). Before the interview, all subjects 
signed informed consent after a detailed description of the study. The study protocol 
always began with a neuropsychological assessment. Thereafter, the same 
interviewer conducted the interview. After the interview, the subjects filled a 
questionnaire containing several scales (Table 4)  
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Table 4.  The Mental Health Interview in the PIF study.  
 
Neuropsychological tests: 
Verbal learning strategies and declarative memory functions CVLT  
(Delis et al., 1987). 
Verbal and visual working memory (WMS-Span Tasks backward)  
(Wechsler, 1987). 
Mental tracking (WAIS-Digit Symbol) (Wechsler, 1981). 
Executive function (Trails B) (Reitan, 1993). 
Attention (WMS-Span Tasks forward; Trails A) (Wechsler, 1987, Reitan, 1993). 
Primary capacity (WAIS-Vocabulary) (Wechsler, 1981). 
  
Interview: 
Information on social and occupational background, and treatment received for 
mental health problems. 
SCID–I interview (First et al., 2001).  
Questions assessing the lifetime occurrence of suicidal ideation and behaviour. 
Questions assessing the family history of mental disorders. 
Global Assessment of Functioning GAF and Social and Occupational Functioning 
Assessment Scale SOFAS 
  
Questionnaire: 
Health-related quality of life RAND-36 (Hays & Morales 2001),  
Chapman Scales for Psychosis Proneness  
(Chapman et al., 1976, 1978, Eckblad & Chapman, 1983, Eckblad et al., 1983).  
Questions concerning social relationships and childhood experiences 
Questions on seasonal variation of symptoms 
  
Blood samples: 
Three 10 ml tubes blood were drawn for genetic analyses 
 
 
Experienced research nurses conducted the neuropsychological tests and the SCID-I 
interviews. The staff had prior experience of clinical work and they had previously 
been working in Finnish large scale genetic studies on schizophrenia and bipolar 
disorder (Ekelund et al., 2001, Paunio et al., 2001, Soronen et al., 2008, Tuulio-
Henriksson et al., 2002) and had also been conducting interviews using SCID and 
administering neuropsychological tests full-time since 1998. All research staff 
participated in a one-month training period in March 2002 and they rated interviews 
simultaneously to ensure the inter-rater reliability. All SCID interviews were 
reviewed with a clinical supervisor (Jukka Hintikka, Jaana Suvisaari, Timo 
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Partonen, and Tuula Kieseppä), and final ratings and diagnoses were based on 
consensus between the interviewer and the clinical supervisor.  
4.1.5 The final diagnostic assessment 
For the final diagnostic assessment, all case notes from hospital and outpatient 
treatments for mental health problems were collected with the approval of the 
Finnish Ministry of Social Affairs and Health. Case notes were collected for both 
those who did and did not participate in the SCID-I interview. Case notes were 
collected first using information from the Hospital Discharge Register and self- 
reports of mental health care contacts from the interview. When case notes revealed 
other contacts, notes from these contacts were systematically collected, too. For 
those who did not participate in the interview and had no register diagnoses, case 
notes from primary care centres were collected and further records of treatment for 
mental health problems were collected based on this information. Case notes of 
subjects who did not report any mental health problems or health care contacts in the 
interview, and had no register information on mental health treatments were not 
collected. Case records of those who had declined from the Health 2000 baseline 
study were neither collected.  
 
The final best-estimate diagnoses were made using the DSM-IV-TR criteria 
(American Psychiatric Association, 2000) by three clinicians Jaana Suvisaari, Jonna 
Perälä and Samuli Saarni. Diagnostic evaluation was based on all available, 
systematically evaluated longitudinal information from the subject and/or data 
provided by other professionals, e.g. the interview and/or case records. Definite 
evidence of psychotic symptoms was required for diagnosing a psychotic disorder. 
All symptoms at any phase of the illness were taken into account in diagnosing the 
entire episodes of illness.   
 
The final diagnostic assessment was made for 692 study subjects and 140 controls. 
The first 20 cases were assessed together to ensure the consistency in ratings 
between rates. Thereafter, the reliability of diagnoses was tested by selecting 136 
cases. These cases were selected mainly among study subjects with a diagnosis of 
any psychotic disorder or bipolar disorder according to the National Hospital 
Discharge Register (screening information) or according to the SCID interview. 
Selected cases were first rated separately by all three raters. In case of disagreement, 
a consensus diagnosis was made together. All problematic cases were reviewed 
together in meetings and consensus diagnoses were made for them together. The 
“probable” category was not used. If there was any uncertainty whether the 
symptoms were definitely psychotic or not, the axis I diagnosis was deferred. If the 
diagnostician was confident about the presence of psychosis, but there was not 
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enough information to assign a specific DSM-IV psychotic diagnosis, psychotic 
disorder NOS was diagnosed. 
 
Cases with possible substance-induced psychotic disorders were also reviewed by 
Adjunct Professor Kimmo Kuoppasalmi, who is an expert in this area. In cases of 
disagreement, the final diagnosis was based on his review. It was not always 
possible to evaluate the diagnostic criteria whether the person had insight on 
psychotic symptoms being substance-induced or not. Therefore, if the person had 
specifically sought help for psychotic symptoms related to substance or alcohol use, 
the criteria that symptoms were in excess of the expected effects of intoxication and 
withdrawal was judged to be met. If a subject had had a definite secondary 
psychosis separately from primary psychotic disorder, e.g. substance induced 
psychosis prior to emerging “functional psychosis” or a psychotic disorder due to 
GMC after clear remission from functional psychosis, both lifetime diagnoses were 
assessed.  
 
In some cases there was not enough information to assess the exact relationship 
between affective and psychotic symptoms and to differentiate whether bipolar I 
disorder with psychotic symptoms or schizoaffective disorder was the accurate 
diagnosis. For those cases both bipolar disorder NOS and psychotic disorder NOS 
was diagnosed. In difficult cases of possible bipolar disorder, Professor Erkki 
Isometsä was consulted. 
 
Of all screen-positive subjects included in the final diagnostic assessment, 35.8% 
(248/692) had a lifetime diagnosis of a psychotic disorder. Diagnosis was deferred 
for 18 subjects, 8 of them having had psychotic symptoms. One hundred and forty-
three did not receive any diagnosis: one of them had a coding error in Hospital 
Discharge Register, 18 were selected by the Prescription Register for using 
anticonvulsants, but they used the medication for somatic disease. Twenty-three 
persons came from the Free Medication Register or the Pension Register with a 
diagnosis of major depressive disorder or a specific diagnosis was not available. The 
rest, 101 with no diagnosis were selected by the CIDI screen. Of the subjects with 
the best-estimate DSM-IV diagnosis of any psychotic disorder, 51% (N=127) had 
attended the SCID interview. Of those attended, 60% could have been diagnosed 
accurately on the basis of the SCID interview alone, but in the remaining 40% with 
the interview the case notes were essential for accurate and specific diagnosis. 
Altogether, if case notes had not been included in the diagnostic procedure, 49% 
with the best-estimate diagnosis of a psychotic disorder, e.g. those without SCID 
interview, would have been missed, and further 21% (40% of those with SCID) 
would have obtained a less accurate diagnosis.  
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Kappa values between the three rates were 0.89-0.92 for schizophrenia, 0.91-0.96 
for schizophrenia spectrum disorders, 0.74-0.91 for all non-affective psychotic 
disorders, 0.76-0.97 for affective psychotic disorders and 0.85-0.93 for general 
medical condition or substance-induced psychotic disorder and delirium. Kappa 
values for the Study IV were calculated separately for delusional disorder (range 
from 0.49 to 0.80) and for schizophrenia subtypes; paranoid schizophrenia (0.72 to 
0.74), undifferentiated schizophrenia (0.24 to 0.76) and disorganized schizophrenia 
(1 between all raters). The kappa values were also similar for cases with both the 
SCID interview and case records available versus cases with case records only. 
Subtyping of schizophrenia was defined based on lifetime information of the 
characteristics of the disorder using the DSM-IV hierarchy for schizophrenia 
subtypes. Residual schizophrenia diagnosis was not routinely used. 
4.1.6 Diagnostic categories 
Subjects with the onset of symptoms of psychotic disorder before the end of 2001 
were included in the prevalence analyses. Broad diagnostic category “non-affective 
psychoses” includes schizophrenia, schizoaffective disorder, schizophreniform 
disorder, delusional disorder, brief psychotic disorder and psychotic disorder not 
otherwise specified (NOS). “Other non-affective psychoses" includes all previously 
mentioned, except schizophrenia. “Affective psychoses” includes bipolar I disorder 
with/without psychotic features and major depressive disorder with psychotic 
features. “Substance-induced psychotic disorders” includes psychotic disorder due 
to alcohol or other substances. Psychotic disorders due to general medical condition 
(GMC) also include also vascular dementia with hallucinations or delusions. All 
psychoses comprised non-affective, affective, substance-induced psychotic disorders 
and psychotic disorders due to general medical condition. Alcohol-induced 
deliriums were included in the Study III.  
4.1.7 Control subjects 
To assess the validity of the PIF screen, but also for other research purposes, 174 
controls were randomly selected for the re-interview from all subjects who had 
attended any phase of the Health 2000 Survey. Of the 174 selected controls, 24 were 
also selected by the PIF screen and were included in the screened population in these 
analyses. Of the remaining 150 subjects, 99 (66%) controls were successfully 
interviewed, 29 (19%) declined, 4 (3%) had died, 5 (3%) could not participate 
because of poor health, 7 (5%) had language problems and 6 (4%) were not reached. 
There was enough information from interview and/or case notes for diagnostic 
assessment for 140 (93%) of the 150 control subjects. One of the 150 screen- 
negative controls had a diagnosis of psychotic disorder due to dementia, but none of 
them had a primary psychosis. 
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4.1.8 Non-response group 
Information from the registers was used to estimate the effect of non-response. Only 
451 (5.4%) of the 8028 individuals had declined from the baseline Health 2000 
Survey, including 32 screen-positive subjects. In addition, neither interview nor case 
notes from 22 subjects of the screened population were obtained. These subjects did 
not differ in age (mean age 54 and 55 years, p=0.25, respectively) or gender (47% 
and 48% males, p= 0.59, respectively) from subjects with best-estimate diagnoses. 
The effect of non-response on lifetime prevalence estimates was estimated by using 
a register diagnosis of non-affective psychotic disorder or affective psychotic 
disorder or any psychotic disorder in The National Hospital Discharge Register. In 
the Free Medication and Pension registers MDD diagnoses 296 in ICD-8 and ICD-9 
and F32 or F33 in ICD-10 with three first digits were not included, as the psychotic 
form of the disorders could not be identified (N=10). Thus, altogether 34 of the 44 
non-responders with a register diagnosis were included.  Register diagnoses of these 
subjects were recorded to data and corrected prevalence rates were calculated 
separately.  
4.2 Other Measures  
4.2.1 Information collected during the diagnostic evaluation 
In addition to assigning diagnoses, the three diagnosticians filled in the Major 
Symptoms of Schizophrenia Scale (MSSS, Supplement 2) (Fanous et al., 2004, 
Kendler et al., 1993, 1998) based on lifetime occurrence and severity of symptoms. 
Eleven key symptomatic variables also reported by Kendler et al. (1993, 1998), were 
used: delusions (any), bizarreness of delusions, hallucinations, positive thought 
disorder, e.g. loosening of associations, catatonic symptoms, affective deterioration, 
e.g. restricted or blunted affect, negative thought disorder, depressive symptoms and 
manic symptoms, chronicity of course (from single episode with recovery to chronic 
course with continuous psychotic symptoms) and the level of outcome (from full 
recovery to very poor outcome). Chronicity of course was rated to all those with any 
psychotic or affective disorder and outcome for those with any psychotic disorder. 
The ratings reflected clinical judgement and included the severity and duration of 
the symptom, and its relative prominence over the entire course of the illness 
(Kendler et al., 1995). All of these variables were coded on a five-point scale, with 
the exception of outcome which was coded on a four-point scale. The symptomatic 
variables were coded as follows: 1=clearly not present, 2=possibly present but 
subthreshold, 3=clearly present but moderate, 4=clearly present and prominent, 
5=clearly present and severe. The course of disorders was coded as follows: 
1=single episode, 2=multiple episodes, full recovery between episodes, 3=multiple 
episodes, partial recovery, 4=chronic course with exacerbations and 5=chronic 
course without exacerbations. Outcome was rated as follows: 1=recovery, 2=mild 
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deterioration, 3=moderate deterioration and 4=marked deterioration. The ratings of 
the course and outcome were done only if information from interview and/or 
medical records were detailed enough and extended until the year 2001. The MSSS 
has been used earlier, e.g. in Roscommon Family Study (Kendler et al., 1995), 
Helsinki High-Risk Study (Niemi et al., 2004), and Irish Study of High-Density 
Schizophrenia Families (Kendler et al., 2000).  This study also assessed the Global 
Rating of Bizarre Behaviour item from the Scale for the Assessment of Positive 
Symptoms SAPS (Andreasen, 1984), and the Global Rating of Avolition-Apathy 
and of Anhedonia-Asociality items from the Scale for the Assessment of Negative 
Symptoms SANS (Andreasen, 1982). These ratings were made on a six-point scale, 
ranging from 0=not at all to 5=severe. 
 
Information on treatment contacts for mental health and addiction problems during 
lifetime, age at the first treatment, lifetime and current antipsychotic medication and 
age at onset of psychotic symptoms were also collected based on all available 
information. Hospitalizations and involuntary treatments were assessed based on the 
Hospital Discharge Register information since the year 1969 and from case records 
before the time the register was established. Persons entitled to costfree outpatient 
medication were identified from the Medication Reimbursement Register of the 
Social Insurance Institution. Using global impression on current symptoms and 
functional capacity, subjects without current treatment were grouped into those who 
a) no longer needed treatment (sustained remission), b) had declined or dropped out 
from treatment and c) would have needed treatment but did not have it available 
either because they had never been diagnosed as having a mental disorder, or 
because treatment contact had been terminated by the health care system. 
4.2.2 Sociodemographic variables 
The Finnish Population Information System was used to obtain information on age, 
gender, and place of birth and residence, which are coded for each Finnish citizen. 
Household income was obtained from the registers on taxes and welfare benefits. It 
was adjusted for household size using the OECD equivalence scale, where the first 
adult of a household is weighted as 1.0, other adults as 0.7, and children less than 18 
years old as 0.5 (OECD, 1982). The study sample was grouped into tertiles 
according to household income. Self-reported information on marital status, level of 
education and employment status was collected during the health interview of the 
Health 2000 Survey.  
4.2.3 Geographic variables 
There is no standard method for defining urbanization (Harrison et al., 2003). In this 
study, the place of residence was categorized into urban and rural (including semi-
urban and rural) areas according to the official classification by Statistics Finland 
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(2001). Municipalities are classified according to the proportion of the population 
living in population centres and by the population of the largest population centre. 
According to this classification in the year 2000, 61% of the Finnish population 
lived in urban areas. The municipalities at the time of birth were categorized as 
urban or rural based on the 1960 census. According to this, 25% of the Finnish 
population lived in municipalities classified as urban. To compare different 
classifications of urban-rural environment, different classifications of urbanization 
of the place of residence were also used such as a) according to the number of 
inhabitants in the municipality (city >50 000, other town 10 000-49 999, rural < 
10 000 inhabitants, Statistics Finland, 2001), b) the population density per km2 of 
land divided in quintiles, and c) capital area (city), other towns (at least 90% of the 
inhabitants reside in the population centre, or the population of the biggest centre is 
over 15 000, Statistics Finland, 2001), and rural areas.  
 
For the regional analysis, Finland was divided into five university hospital regions. 
These are the same areas as used in the stratification during the Health 2000 sample 
selection: South, SouthWest, West, East and Northern Finland (Figure 1 in the 
original Study II). Of the subjects in the Health 2000 population living in urban 
areas, 44.4% resided in the South, 12.5% in the SouthWest, 23.3% in the West, 
10.0% in the East  and 10.0% in the North.   
4.2.4 Alcohol-related variables 
Lifetime diagnoses of alcohol dependence were based on the CIDI interview in the 
health interview of the Health 2000 Survey. The total number of CIDI mental health 
interviews was 6005, amounting to 75% of the original sample. If the criteria of 
alcohol dependence (AD) had not been fulfilled within the past 12 months, the 
subject was determined as being currently in remission from AD (Pirkola et al., 
2006). The subjects were asked in the CIDI when they drank their first drink of 
alcohol and the age at onset of any of the symptoms of AD. As a part of the baseline 
survey, standardized questions about current alcohol consumption were asked in a 
questionnaire. This information was used in calculation of weekly consumption of 
alcohol. Parental alcohol use and mental health problems at the time when the 
subject was 16 years or younger, were asked in the same questionnaire. 
  
Of the subjects with final diagnosis of alcohol-induced psychotic disorder or 
delirium, 74.4% had attended the CIDI interview even though many of them had not 
reported about the psychotic symptoms. Those who did not attend differed not in 
terms of age, gender, number of hospital treatments, or age at first hospital treatment 
from those who attended the interview. 
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Hospital treatments for alcohol-related disorders and traumas were collected from 
the Finnish Hospital Discharge Register (from 1969 to December 2002). The total 
number of hospital treatments and age at the first hospital treatment for alcohol-
related disorders and traumas were collected. The diagnostic codes included are 
presented in the original Study III, Table DS1. Information on deaths was obtained 
from the Census data of the Social Insurance Institution of Finland (until 
01.03.2008). The causes of deaths were available for the deaths that had occurred 
before the end of the year 2006 from the Causes of Death Register of Statistics 
Finland. They were classified into natural and unnatural deaths, including suicides. 
Alcohol-related deaths comprised all deaths where either the underlying cause or 
one of the contributory causes was attributed to alcohol, such as alcohol 
intoxications (including ICD-10 diagnoses E244, E52, F10, G312, G621, G721, 
1426,  K292, K70, K860, O354, P043, T51, X45, Z502, Z714, Z724, Mäkelä et al., 
1999). 
4.3 Statistical analysis  
All analyses were conducted using SAS-callable SUDAAN Release 9.0 (Research 
Triangle Institute, 2004), which is able to take into account the two-stage cluster 
sampling design. The SAS 8.02 (SAS Institute Inc., 1999) was used in the Studies I-
III and version 9.1.3 (SAS Institute Inc., 2002) in the Study IV. Sampling design 
was included in all statistical analyses to obtain figures representing the Finnish 
general population. Post-stratification weights were used to adjust for the 
oversampling of individuals aged 80 years and over. Whenever the data were 
obtained from the Health 2000 baseline survey, another set of weights were used to 
correct the effect of non-response in the Health 2000 Survey. The weights were 
calibrated by Statistics Finland (Lehtonen and Pahkinen, 2004).  
4.3.1 Statistical analysis in the Study I 
Lifetime prevalences were estimated by calculating proportions for dichotomous 
variables and asymmetric 95% confidence intervals for percentages were calculated 
using the logit transformation (Research Triangle Institute, 2004 pp. 243-244). 
Prevalences in different age groups and among women and men were compared 
using the chi-square statistics within the survey design. Values of p<0.05 were 
considered statistically significant. To estimate the effect of non-response, the 
prevalences were recalculated, by using register diagnoses for those non-respondents 
who had a register diagnosis of psychotic disorders. Inter-rater reliability in the final 
diagnoses of psychotic disorders was evaluated using unweighted kappa statistic 
(К). Concordances between the screens and the DSM-IV research diagnoses were 
evaluated by calculating simple К (Fleiss, 1981), sensitivity, specificity, and positive 
and negative predictive values (Akobeng, 2006). In each screen, the total number of 
subjects who participated in that particular phase of the baseline study was included.  
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4.3.2 Statistical analysis in the Study II 
In the Study II, the non-response group was included in the analysis. The highest 
possible number of subjects for whom the data were available were included in the 
analysis. Schizophrenia, other non-affective psychotic disorders, affective psychoses 
and any psychotic disorders, also including substance-induced and psychotic 
disorders due to general medical condition, were modelled separately as groups. 
Proportions of subjects with different diagnoses in different sociodemographic 
groups were calculated. Also percentages of subjects being born or resident in urban 
and rural areas and different geographic areas were calculated. The differences were 
tested using the chi-square statistics within the survey design. Lifetime prevalence of 
psychotic disorders in different regions was estimated as predicted margins to obtain 
estimates adjusted for age and gender (Research Triangle Institute, 2004). Logistic 
regression models were used to determine whether some regional variables were 
independently associated with different psychotic disorders.  
4.3.3 Statistical analysis in the Study III   
In the Study III, subjects with alcohol-induced psychotic syndrome, alcohol 
dependence without alcohol-induced psychotic syndrome and general population 
without alcohol dependence were compared. Comparisons were made also between 
subjects with alcohol-induced psychotic disorder and delirium. Different analyses 
included always the largest possible number of participants in that particular phase 
of the study for whom the data were available. Proportions of subjects in different 
categorical groups were calculated, and the differences were tested using the chi-
square statistics. Predicted margins were applied to adjust means and prevalences for 
age and gender (Heistaro, 2008 p. 191, Lee, 1981). Logistic regression was used to 
calculate odds ratios for categorical variables and linear regression was used in the 
cases of continuous variables. All the models were always adjusted for age and 
gender.  
 
Cox proportional hazards models were used to examine the effect of alcohol-
induced psychotic syndrome on mortality, when controlling for age and gender. The 
analysis of mortality and also of alcohol-related medical comorbidity, were 
restricted to population under 70 years. Only one subject with alcohol-induced 
psychotic disorder or delirium was found to be older than 70 years at the baseline. 
Hazard ratios (HR) and 95% confidence intervals were calculated for mortality 
among subjects with alcohol-induced psychotic disorder and delirium, alcohol 
dependence, and the rest of the sample. As the sample size was small, scaled score 
residuals were used for measuring the influence of individual observations 
(Therneau et al., 2000, Thompson et al., 2003). Scale score residuals measure the 
influence of one observation on the maximum partial likelihood estimate of a 
coefficient when deleting each observation in turn. The magnitudes of the scaled 
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score residuals were quite similar and near zero. That indicates that none of the 
observations were too influential individually. 
4.3.4 Statistical analysis in the Study IV  
Comparisons were made between subjects with delusional disorder, and with 
subtypes of schizophrenia. Paranoid, undifferentiated and disorganized 
schizophrenia were included. Catatonic subtype (N=3) was too rare to be analysed 
separately. Differences in age and mean age at onset between the groups were tested 
using analysis of variance, and post hoc differences between the groups were 
compared with Tukey's honestly significant difference. Differences in ordinal 
variables (MSSS, SANS and SAPS ratings) between the groups were tested using 
Kruskal-Wallis test, and differences in categorical variables with the the chi-square 
statistics test. The number of hospital treatment days was a highly skewed variable, 
and Kruskal-Wallis test was used to analyze between-group differences. 
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5 Results 
5.1 The screening of psychotic disorders (STUDY I) 
The psychosis screen found 248 subjects with lifetime diagnosis of psychotic 
disorder. One subject with psychosis due to GMC was found among the control 
sample. The number and the proportions of subjects within the same diagnostic 
category found by specific screens are presented in Table 5 in original Study I. The 
National Hospital Discharge Register alone captured 76%-81% of subjects with non-
affective or affective psychotic disorders, while it was not as effective in finding 
substance-induduced psychoses or psychoses related to GMC. The CIDI psychotic 
symptoms screen was able to capture at best less than third of the non-affective 
psychotic disorders and substance-induced psychotic disorders. Altogether, if the 
only screen had been the Hospital Discharge Register, CIDI section G or self-
reported psychotic disorder 75%, 27% and 25% of the cases with any psychotic 
disorder would have been found, respectively. Excluding the registers, other screens 
found 52.4% of the subjects with psychotic disorders. The CIDI manic symptom 
screen alone detected only 25% of the subjects with BPI.  
 
The Prescription register is not included in these estimates. The register was used to 
complement the screening of bipolar I disorder. All Health 2000 subjects not 
selected by other screens were further assessed according to anticonvulsants or 
lithium use. Of the 36 subjects found, one had psychosis due to GMC and three had 
substance-induced psychoses. None of the four subjects selected by the CIDI 
remarks section had psychotic disorder as the final diagnosis.  
 
Table 5 presents the concordance between different parts of the screen and the best-
estimate diagnoses of any psychotic disorders as a group. The total number of 
subjects for each screen included all participants in that phase of the study and the 
subjects in the non-response group were excluded. The lifetime prevalence of 
psychotic disorders in the case that different parts of the screens would have been 
used is presented in the Figure 3. 
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Table 5. Concordance Between the Different Parts of the Screen and the Best-
Estimate DSM-IV Diagnoses of Any Psychotic Disorders  
Screen Kappa (95%  CI) Sensitivity Specificity PPV NPV
National All registers* 0.72 (0.68-0.76) 86.1 98.3 63.8 99.5
registers
Psychotic disorder in Hospital 0.80 (0.76-0.84) 75.3 99.7 88.4 99.2
Disharge Register
Psychotic disorder 0.58 (0.52-0.63) 60.9 98.5 58.2 98.7
in Other Registers**
CIDI CIDI all sections 0.25 (0.19-0.30) 43.5 95.1 19.7 98.4
CIDIG psychotic symptoms  0.32 (0.25-0.38) 41.5 97.1 28.5 98.4
CIDIF manic symptoms 0.12 (0.06-0.17) 12.1 98.3 16.0 97.6
CIDIP other symptoms related  0.27 (0.20-0.35) 22.4 99.1 40.0 97.9
to psychosis
Health Psychosis assessed 0.37 (0.29-0.45) 24.5 99.9 91.0 98.0
2000 by physician
Self-reported psychoses 0.38 (0.31-0.44) 26.7 99.9 81.8 97.6
Abbreviations: CIDI, Composite International Diagnostic Interview; PPV, positive predictive value;
NPV, negative predictive value
* Includes Hospital disharge register, the Medication Reimbursement register and the Pension register 
** Includes the Medication Reimbursement register and the Pension register  
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Figure 3. Lifetime Prevalence of All Psychotic Disorders if Different Screens Would 
Have Been Used.                                                                                  
Abbreviations: PIF, Psychoses in Finland; CIDI, Composite International 
Diagnostic Interview 
5.2 Lifetime prevalences of psychotic disorders (STUDY I) 
LTP estimates of psychotic and bipolar I disorders and their 95% confidence 
intervals are presented in Table 6. The most prevalent specific psychotic disorders 
were schizophrenia 0.87%, psychotic disorder NOS 0.45% and alcohol induced 
psychotic disorder 0.41%.  
Register diagnoses of specific psychotic disorders were found in 34 subjects of the 
non-response group (N=55) of the PIF study. When these diagnoses were included, 
LTP in any psychotic disorder increased to 3.48%, in non-affective psychotic 
disorder to 2.29%, in schizophrenia to 1.00%, and in affective psychoses to 0.62%. 
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Table 6. Lifetime Prevalence Estimates and 95% Confidence Intervals of DSM-IV 
Psychotic and Bipolar I Disorders  
        Total                 Total, including 
non-respondents
%      (95% CI)          %     (95% CI)
Non-affective psychotic disorders 1.94 (1.63-2.29) 2.29 (1.95-2.69)
Schizophrenia 0.87 (0.68-1.11) 1.00 (0.79-1.25)
Schizoaffective disorder 0.32 (0.21-0.46)
Schizophreniform disorder 0.07 (0.03-0.16)
Delusional disorder 0.18 (0.11-0.30)
Brief psychotic disorder 0.05 (0.02-0.14)
Psychotic disorder NOS 0.45 (0.33-0.62)
Affective psychotic disorders 0.59 (0.45-0.77) 0.62 (0.47-0.80)
Bipolar I disorder 0.24 (0.16-0.37)
with psychotic features 0.12 (0.06-0.23)
without psychotic features 0.12 (0.07-0.23)
MDD, with psychotic features 0.35 (0.24-0.51)
Substance-induced psychotic disorders 0.42*  (0.30-0.59) 0.43 (0.31-0.60)
Alcohol-induced 0.41 (0.29-0.57)
Other substance-induced 0.03 (0.01-0.11)
Psychotic disorders due to a GMC 0.21 (0.14-0.32) 0.22 (0.15-0.34)
Any psychotic disorders 3.06* (2.66-3.51) 3.48 (3.06-3.96)
* In the estimated prevalence, each individual has only been counted once  
 
If all subjects with bipolar disorder NOS because of insufficient information would 
have BPI, its prevalence increased to 0.39%. If also register diagnoses of BPI in 
non-responders were included, the LTP would be 0.42%. 
 
Gender differences were found only in schizoaffective disorder, GMC induced 
psychotic disorders and substance-induced psychotic disorders (Table 3 in original 
Study I). Women had more schizoaffective disorders and GMC induced psychoses 
compared with men. Substance-induced psychotic disorders were more common in 
men and most common in the age group 30-54 years (Table 4 in original Study I). 
The LTP of GMC induced psychotic disorders increased markedly from 0.74% in 
the age group 65 years and older to 1.71% among subjects 80 years and older. Most 
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(92.9%) subjects in this group had dementia. Delusional disorder was found only in 
the age group 45 years and older. 
 
Sociodemographic characteristic of psychotic disorders (STUDY II) 
Sociodemographic characteristics of subjects with schizophrenia, other non-affective 
psychotic disorders, affective psychotic disorder and any psychotic disorders were 
assessed (Table 2 in original Study I). When adjusted for age and gender, the odds 
of having any psychosis were high among not married, pensioned and unemployed 
persons and among those having low income, or basic education. Being pensioned 
was common among subjects with non-affective psychotic disorders: 70% of them  
pensioned. One third of subjects with non-affective psychotic disorder had reached 
the pension age (63 years) and 87.0% of the pensioned below that age reported 
having disability pension. Only 20% of subjects with non-affective psychotic 
disorders, and 7% of subjects with schizophrenia were employed compared to 57% 
of the rest of the population. 
In schizophrenia, a high OR was found among those who were unmarried, 
pensioned or unemployed and among those having low income. The odds of having 
other non-affective psychotic disorder was high in widowed, never married, 
pensioned, unemployed and persons having low income. In contrast, the odds of 
affective psychoses were high in those divorced or separated and low in the group of 
secondary level education. 
5.3 Geographic differences in lifetime prevalence of psychotic  
      disorders in Finland (STUDY II) 
Lifetime prevalence of psychotic disorders in five university hospital regions of 
Finland is presented in Figure 4.  
 
In separate logistic regression models, after adjusting for age and gender, any 
psychotic disorder was associated with birth in rural areas compared with urban 
birth (OR 0.73, 95% CI 0.54-0.98), and birth in the South (OR 2.18, 95% CI 1.16-
4.09), the West (OR 2.46, 95% CI 1.33-4.54), the East (OR 3.13, 95% CI 1.76-5.55) 
or the North (OR 3.52, 95% CI 1.97-6.31) compared with the SouthWest. 
Associations were also found with residence in the South (OR 1.68, 95% CI 1.02-
2.77), the East (OR 1.87, 95% CI 1.09-3.24) or the North (OR 2.15, 95% CI 1.26-
3.68). In schizophrenia, a high OR was found among those being born in the East 
(OR 3.99, 95% CI 1.22-13.11) or the North (OR 7.72, 95% CI 2.48-24.04) and 
residing in the North (OR 3.00, 95% CI 1.37-6.55). The odds of having other non-  
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Figure 4. Lifetime Prevalence of Psychotic Disorders in Five University Hospital 
Regions of Finland.  Age and Gender Adjusted. 
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affective psychotic disorders were high among those being born or residing in the 
East or the North (Table 2 in original Study II).   
 
When all geographic variables were included in logistic regression model 
concerning any psychotic disorders, the association with region of birth remained 
statistically significant (p=0.02), while associations with region of residence and 
with having birth in rural region attenuated (Table 7). The adjusted results were 
similar for other psychosis groups. The odds ratios for schizophrenia, other non-
affective psychoses and affective psychoses in different regions of birth, adjusting 
for urbanicity, are presented in the Figure 5. 
 
No differences were found in internal migration between persons with any lifetime 
psychotic disorder and non-affected population. 65.1% and 67.8% (p=0.37) still 
lived in the region of birth, respectively. The odds of any psychotic disorders (OR 
1.13, 95% CI 0.87-1.47), schizophrenia (OR 0.89, 95% CI 0.55-1.44), other non-
affective disorders (OR 1.30, 95% CI 0.84-2.00) and affective psychoses (OR 1.43, 
95% CI 0.81-2.53) was similar in subjects who had migrated to other regions of the 
country as in subjects who had stayed in the area of birth. 
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Table 7. The Associations of Any Psychotic Disorders with Urbanicity and 
Regions of Birth and Residence. Age and Gender Adjusted.  
 
Any psychotic disorder
OR (95%  CI)
Place of birth
Rural 1
Urban 0.79 (0.57-1.09)
Region of birth
SouthWest 1
South 2.09 (0.98-4.42)
West 2.49 (1.23-5.02)*
East 2.97 (1.42-6.20)*
North 3.30 (1.54-7.09)*
Place of residence
Rural 1
Urban 1.03 (0.76-1.40)
Region of residence
SouthWest 1
South 1.13 (0.56-2.26)
West 0.94 (0.45-1.94)
East 1.00 (0.46-2.18)
North 1.07 (0.48-2.34)
* Significant at the 0.05 level.  
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Figure 5. The Odds Ratios for Schizophrenia, Other Non-Affective Psychotic 
Disorders and Affective Psychotic Disorders for birth in Five Main 
Regions of Finland. Age, Gender and Urbanicity adjusted.                         
* Significant at the 0.05 level. 
 
5.4  Alcohol-induced psychotic syndrome in the general 
       population (STUDY III) 
The lifetime prevalence of alcohol-induced psychotic disorder was estimated at 
0.41% (95% CI 0.29–0.57, N=31) and delirium at 0.18% (95% CI 0.11–0.32, 
N=14). Six subjects had had both diagnoses. When each individual was counted 
once, the LTP for the total alcohol-induced psychotic syndrome was 0.51% (95% CI 
0.38-0.70, N=39). The majority of subjects with AIPS were men, among whom the 
highest LTP 1.77% (95% CI 1.06-2.94) was found in the age group 45–54 years 
(Figure 6).  
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Figure 6. Lifetime Prevalence of Alcohol-Induced Psychotic Disorder and Delirium by 
Age Group and Gender.                                                                                 
* Difference between men and women significant at the 0.05 level.   
In subjects with alcohol-induced psychotic disorder, the subtype "with 
hallucinations" was common (N=30, 97%), and 53% of them had had delusions in 
addition to hallucinations. Most subjects (87%) had had multiple episodes of 
alcohol-induced psychosis with full recovery between the psychotic episodes.  
 
Comorbid mental health disorders were found in 64% of the subjects with AIPS, 
subjects with alcohol-induced psychotic disorder having higher rates (76%) than 
subjects with delirium (43%). The most common comorbid disorders were affective 
disorders, followed by personality, other substance use disorders and anxiety 
disorders. Other substance use disorders (N=10, 26%) included six cases with 
sedative dependence or abuse, two cases with polysubstance dependence,  one case 
with sedative and polysubstance dependence, and one case with opioid, cannabis 
and polysubstance dependence. During the episodes of the alcohol-related 
psychosis, there was no evidence found of the concurrent substance use.  
 
Five subjects (12.8%) developed some other primary psychotic disorder 5 to 10 
years after the alcohol-induced psychotic episode. One subject with alcohol-induced 
psychotic disorder developed schizophrenia, one schizophreniform disorder and one 
psychotic disorder NOS. One subject with delirium developed bipolar disorder with 
psychotic features and one had a later episode of brief psychotic disorder.  
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All subjects with AIPS had had some mental health or alcohol treatment unit 
contact. 82% had had psychiatric hospital treatment during their lifetime, but only 
59% had sometimes been treated in psychiatric hospital with a diagnosis of any 
psychotic disorder. The first treatment unit for alcohol-induced psychosis was 
psychiatric hospital in 46%, primary health care centre in 28%, alcohol treatment 
settings 8%, general hospital 3% and psychiatric outpatient care 3%. 13% had 
received no treatment for the first episode.  
 
Long and heavy use of alcohol was a usual finding among the subjects with AIPS. 
The mean age at the time of the first ever drink was 15.5 years (95% CI 14.4-16.7), 
onset age for alcohol use disorder was 24.6 years (95% CI 22.2-27.1) and for 
psychotic symptoms 34.3 years (95% CI 31.3-37.2) in the subjects with AIPS. The 
mean duration of alcohol use ranged from 14 to 50 years (mean 29.5 years, 95% CI 
26.8 -32.2). Time from the first drink to the onset of psychotic symptoms was 18.4 
years (95% CI 15.4-21.4, range 6-34 years), and from the onset at alcohol use 
disorder to psychotic symptoms 10.4 years (95% CI 7.8-12.7, range 1-28 years). The 
time from the onset of alcohol use disorder to the first treatment contact for alcohol 
problems was 6.8 years (95% CI 4.5-9.1) and to the first treatment for psychosis 
10.4 years (95% CI 7.9-12.9). No differences were found in current remission rates 
or alcohol consumption between subjects with alcohol dependence with or without 
psychosis. 
 
The LTP for AIPS among subjects having alcohol dependence was 4.8% (95% CI 
3.23–7.17), and for alcohol-induced psychotic disorder 4.0% (95% CI 2.6–6.1) and 
for delirium 1.9% (95% CI 1.0–3.6). There was no difference in the mean ages (45.0 
and 46.8 years) between those with and without psychosis. The odds of having had 
AIPS were higher in subjects having low income, being never married, unemployed, 
and belonging to the age group 45–54 (Supplement table DS2 in original Study III) 
compared with subjects with alcohol dependence only. Subjects with AIPS reported 
more parental and specifically paternal alcohol problems, and more paternal mental 
health problems than subjects with alcohol dependence only. The results were 
similar when subjects who later developed primary psychotic disorder were 
excluded. 
 
Alcohol-related hospital treatments in subjects with AIPS, alcohol dependence only 
and the rest of the study population are presented in Table 4 in original Study III. 
Hospital treatments for any alcohol-related causes were found from the National 
Hospital Discharge Register for 91% of the subjects with AIPS, 16% with alcohol 
dependence and 3% of the rest of the sample. Subjects with AIPS had younger age 
(mean 32.9, 95% CI 30.2- 35.6) at first treatment and higher number of treatments 
(mean 6.5 95% CI 2.8-10.2) compared with those with alcohol dependence (39.8 
years, 95% CI 37.6-42.1, mean 2.8, 95% CI 1.9-3.7) or without this (40.9 years, 
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95% CI 38.9-42.9, mean 2.5, 95% CI 1.8-3.3, respectively). The OR of having had 
hospital treatments for any intoxications, other substance use, alcohol-related liver 
disorders, gastritis, fractures, and head injuries were higher in subjects with history 
of AIPS compared with subjects with alcohol dependence only and the study 
population without alcohol dependence. Pancreatitis in subjects with AIPS was more 
common than in subjects without alcohol dependence, but no difference was found 
in comparison with subjects with alcohol dependence.  
 
During follow-up from 2000 to 2008, 37% of subjects with AIPS had died (Table 8). 
No differences were found in mortality between subjects with alcohol-induced 
psychotic disorder (40.0%) and delirium (30.8%) (HR 1.38, 95% CI 0.43-4.48). The 
risk of death was substantially higher among subjects with AIPS compared to 
subjects with alcohol dependence (HR 12.33, 95% CI 6.28-24.21).  The underlying 
cause of death was available for 10/14 participants with AIPS: 4 of the deaths were 
natural, 2 were suicides and 4 were other unnatural deaths. Six of these deaths were 
alcohol-related according the register data.  
 
 
 
Table 8. Deaths and Hazard Ratios for Death among Persons with Alcohol-
Induced Psychotic Syndrome or Alcohol Dependence, Compared with 
the Rest of the Sample 
Deaths 2000-2008
N % (95% CI) HR (95% CI)
No alcohol dependence (N=5891) 242 4.11 (3.57-4.72) 1
Alcohol dependence without alcohol-induced psychotic syndrome (N=443) 29 6.54 (4.51-9.41) 1.61 (1.05-2.45)
Alcohol-induced psychotic syndrome (N=38) 14 36.84 (22.13-54.50) 19.91 (11.48-34.53)
Individuals over 70 years were excluded.  Age and gender adjusted.  
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5.5 Delusional disorder and schizophrenia subtypes 
The lifetime prevalence of delusional disorder was 0.18% (95% CI 0.11-0.30). The 
lifetime prevalence of schizophrenia subtypes were: paranoid schizophrenia 0.24% 
(95% CI 0.15-0.37), undifferentiated schizophrenia 0.42% (95% CI 0.30-0.59), and 
disorganized schizophrenia 0.16 % (95% CI 0.09-0.27).  
 
Differences between men and women were not found in delusional disorder, 
paranoid schizophrenia, or undifferentiated schizophrenia. On the contrary, there 
were more men than women in the disorganized schizophrenia group compared with 
the other groups. The mean age at onset of psychotic symptoms was oldest in 
delusional disorder and youngest in disorganized schizophrenia, while paranoid and 
undifferentiated schizophrenia did not differ from each other (Table 2 in original 
Study IV). 
 
The severity of delusions did not differ between any of the groups, but there were 
differences in all other symptom dimensions (Table 2 in original Study IV). 
Paranoid schizophrenia and delusional disorder resembled each other in having 
milder negative thought disorder, catatonic symptoms, and anhedonia/asociality.  
However, compared with any of the schizophrenia subtypes, persons with delusional 
disorder had milder hallucinations, bizarre delusions, positive thought disorder, 
affective deterioration, manic symptoms, bizarre behaviour, and avolition. Persons 
with paranoid schizophrenia had less severe formal thought disorder, affective 
deterioration, avolition, and catatonic symptoms than persons with undifferentiated 
schizophrenia. Persons with disorganized schizophrenia had had more severe 
positive and negative thought disorder, affective deterioration, bizarre behaviour and 
avolition than subjects in all other groups 
 
Based on the longitudinal information, the course of delusional disorder was less 
chronic than in undifferentiated and disorganized schizophrenia, and the course of 
paranoid schizophrenia less chronic than in disorganized schizophrenia. Outcome 
was better in delusional disorder than in any of the schizophrenia subtypes, and 
worse in disorganized schizophrenia compared with paranoid and undifferentiated 
schizophrenia (Table 3 in original Study IV).  
 
All persons with schizophrenia had had contact with psychiatric treatment and all 
but one had used antipsychotic medication. Of the persons with different 
schizophrenia subtypes, 70%-92% also had current treatment contact and 65%-92% 
had current antipsychotic medication. Although 81% of persons with delusional 
disorder had also had psychiatric treatment contact during lifetime and 63% of them 
had used antipsychotic medication, the current situation was different from the 
schizophrenia subtypes; only 21% subjects with delusional disorder had current 
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treatment contact, and 14% were currently using antipsychotic medication. Of 
persons with delusional disorder not having current treatment contact, 18% did not 
need treatment anymore (sustained remission), 27% had declined from treatment, 
and 54% needed treatment, but did not have it available. Of persons with 
schizophrenia without current treatment contact 14% no longer needed treatment, 
57% had declined from treatment, and 21% did not have treatment available.  
 
Lifetime psychiatric hospitalizations were less common in persons with delusional 
disorder (50%) than in persons with any schizophrenia subtype (84%-100%), as 
were involuntary hospital treatments (13% and 61%-92%, respectively). The most 
notable difference between the groups was in the lifetime duration of 
hospitalizations. At the extreme ends were persons with disorganized schizophrenia, 
who had spent on average almost 10 years in inpatient treatment, and persons with 
delusional disorder, whose average duration of hospitalizations was only 21 days 
during their lifetime. Persons with delusional disorder who had had a psychiatric 
hospital treatment tended to have more severe symptoms and course of illness than 
those without hospital treatments. Their mean age at onset was also lower (46.2 
years) compared with persons with delusional disorder without hospitalizations 
(57.2 years). However, none of these differences were statistically significant.  
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6 Discussion 
The present thesis investigated psychotic disorders and their correlates in the Finnish 
adult population sample. The thesis was based on the Health 2000 Survey and 
especially on the Psychoses in Finland (PIF) study. The aims of this thesis were to 
estimate the lifetime prevalence of different psychotic disorders as accurately as 
possible, to evaluate sociodemographic and geographic factors associated with the 
disorders, and to study in more detail the epidemiology and clinical features of 
alcohol-induced psychotic disorders, delusional disorder and subtypes of 
schizophrenia. 
6.1 Summary of the main findings 
Psychotic disorders were found to be common in the Finnish adult population. 
Approximately 3.5% of persons aged 30 years or over had met the criteria for any 
psychotic disorder during their lifetime. Non-affective psychoses (2.29%) were 
more common than affective psychoses (0.62%), while substance-induced psychotic 
disorders were common in working age men and psychoses related to general 
medical condition in the oldest age groups. 
 
Detecting psychotic disorders from the general population reliably and diagnosing 
them accurately required collecting information systematically from several sources. 
National registers, especially the National Hospital Discharge Register were the 
most reliable and effective in screening psychotic disorders from the general 
population. Composite Structured Diagnostic Interview (CIDI) alone was not 
sufficient in screening psychotic disorders.  
 
As expected, psychotic disorders were generally associated with socioeconomic 
disadvantage like being unmarried, pensioned or unemployed; having low income 
level or basic education. Affective psychoses were associated with higher level of 
education and income compared with other psychotic disorders. Highest prevalence 
of psychotic disorders was found in northern and eastern, and lowest in south-
western parts of Finland. The area of birth was a more important determinant of the 
risk of psychosis than the area of residence.  
 
Alcohol-induced psychotic disorder or delirium were common (LTP 1.8%) among 
men aged 45-54. Subjects with AIPS had on average a long history of heavy alcohol 
use before the onset of psychotic disorders, they had often had both hallucinations 
and delusions during the psychotic episodes. Most (64%) of them had other 
comorbid mental disorders. Subjects with AIPS belonged to lower socioeconomic 
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group, they had been treated in hospital for alcohol-related causes more often and at 
younger age compared with subjects with alcohol dependence. The mortality risk 
during eight years follow-up was 20 times higher in subjects with AIPS compared 
with general population, and 12 times higher compared with alcohol dependent 
subjects. 
 
Delusional disorder was found to be a different disorder from paranoid 
schizophrenia and from other schizophrenia subtypes. It was characterized by high 
age of onset, absence of other symptoms than delusions and relatively good 
outcome. Disorganized subtype of schizophrenia also showed good validity. It was 
associated with early onset, male preponderance, chronic course, long 
hospitalizations and poor outcome.  Paranoid and undifferentiated schizophrenia 
showed no marked clinical differences. All subjects with schizophrenia had had 
some treatment contact and 70% also had current treatment. Almost all subjects with 
delusional disorder also had an earlier treatment contact, but only 21% had current 
treatment, even though in most cases this would have been necessary. 
6.2 Lifetime prevalence of psychotic disorders (STUDY I) 
The lifetime prevalence (3.5%) of psychotic disorders was higher than in most 
previous general population surveys using two-stage strategies (Kendler et al., 1996, 
Kessler et al., 2005, van Os et al., 2001). One study, based on the CIDI interview, 
has obtained higher prevalence estimate (4.5%), of all psychoses (Jacobi et al., 
2004).  
 
The results of this study are surprisingly similar with the recent Lundby study 
(Bogren et al., 2009) where a 50-year period prevalence was found to be 4.2% and 
LTP 2.82%. The 50-year period prevalence estimate is higher than the lifetime 
prevalence because it includes all subjects in the original study population cohort, 
also persons deceased before the 50-year follow up. The slightly lower LTP 
represents cohort subjects alive at the 50-year follow up. Although the results are not 
directly comparable, the proportions of non-affective, affective and other psychoses, 
are highly concordant in the Lundby study (53%, 15% and 32%, respectively) and 
PIF (64%, 18% and 18%, respectively, Figure 7). Higher proportion of psychoses 
due to GMC in the Lundby study partly explains the lower proportion of other 
psychoses compared with PIF. The results were also in keeping with the British 
incidence study AESOP, where the distribution of the new onset cases was 
suprisingly similar (67% non-affective, 28 affective, 5% substance induced 
psychoses, Kirkbride et al., 2006). The magnitudes of the psychosis groups were 
also supported by a meta-analysis of British incidence studies (Kirkbride et al., 
2012). 
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Figure 7.  Proportions of psychotic disorders in the PIF study 
The Finnish pioneer of general population surveys, the Mini-Finland Survey 
obtained very similar results 25 years ago, with LTP for functional psychoses 2.2%, 
schizophrenia 1.3% (broad definition) and other psychoses 0.9% (Lehtinen et al., 
1990). The study setting in the Mini-Finland Survey was also a two-stage procedure: 
health examination and register data were used for case ascertainment, and 
information from psychiatric hospital treatments, register diagnoses, as well as a 
semi-structured interview (Present State Examination/CATEGO computer program) 
were the basis for the final clinical diagnostic decision (Lehtinen et al., 1991). 
Different diagnostic classification between studies makes the direct comparison of 
the results difficult. The same concerns other older studies (Astrup, 1989, Torrey, 
1987). 
 
Further support for the high prevalence of psychotic disorders, especially 
schizophrenia, comes from the Northern Finland 1966 Birth Cohort, where the 
cumulative incidence of affective psychoses is even lower than in our study 
(Moilanen et al., 2010). By the age of 34, 111 of approximately 10 000 subjects had 
been diagnosed with schizophrenia, 26 with other non-affective psychoses and 19 
with affective psychoses. The lifetime prevalence of psychotic disorders, including 
psychosis related to dementia, was 2.9% in the UKKI study (Lehtinen et al., 1993).  
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Other modern general population studies on the whole category of psychotic 
disorders using multiple sources of information and best-estimate diagnoses on 
lifetime basis are lacking. Altogether, all these results indicate that psychotic 
disorders are common, and non-affective psychotic disorders the most common 
group in Finland. 
 
The lifetime prevalence of schizophrenia in the Finnish general population was 
0.87%. When register diagnoses in the non-response group were included, the 
prevalence increased to 1.00%. These estimates are considerably higher than the 
median lifetime prevalence 0.4% (0.18-1.16) found in the recent systematic review 
(Saha et al., 2005). Older studies have obtained even higher estimates (Torrey, 1987) 
but comparisons are again difficult due to changes in diagnostic criteria (McGorry et 
al., 1992, Pihlajamaa et al., 2008). In contrast, it is likely that the prevalence of 
schizophrenia in many recent population surveys would have been considerably 
higher if information in healthcare registers and case notes would have also been 
used. Supporting this, the estimates of schizophrenia from the Lundby study are 
concurrent with our results with 50-year period prevalence 1.43% and LTP 0.84% 
(Bogren et al., 2009). Results are also in line with other Finnish general population 
studies (Isohanni et al., 2001, Lehtinen et al., 1990, Moilanen et al., 2010) as well as 
with Finnish register-based studies (Hovatta et al., 1997, Suvisaari et al., 1999), and 
this fact suggests that the prevalence of schizophrenia is relatively high in Finland. 
 
We found no gender difference in the prevalence of schizophrenia in accordance 
with prevalence studies (Bogren et al., 2009, Lehtinen et al., 1990, Saha et al., 
2005). However, incidence (McGrath et al., 2004) and morbid risk (Aleman et al., 
2003) of schizophrenia are higher in males. This discrepancy is a subject for further 
studies. Earlier age of onset in males (Eranti et al., 2012), the preponderance of 
women in later-onset cases (Meesters et al., 2012, Thorup et al., 2007) and 
differences in mortality (Brown 1997, Brown et al., 2010, Heilä et al., 2005, 
Joukamaa et al., 2001, Kiviniemi et al., 2010) may be among the issues that could 
explain this discrepancy (Eranti et al., 2012). However, as the the number of cases is 
small, differences approximately two-fold and over could have been detected in this 
study.  
 
A higher LTP of schizoaffective disorder was found compared with the few recent 
studies where the estimates have varied between 0% and 0.11% (Bogren et al., 2009, 
Scully et al., 2004, Widerlöv, 1997). In a service-based study of individuals over 60 
years, one-year prevalence of 0.14% was found (Meesters et al., 2012). Comparison 
of the estimates is difficult, as the diagnostic thresholds of schizoaffective disorder 
may vary between studies (Jäger et al., 2011). Another question is the diagnostic 
instability, which often occurs during the variable course of the disorder (Laursen et 
al., 2005, 2007, Salvatore et al., 2009, Schwartz et al., 2000, Tohen et al., 2012). In 
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this study, the diagnosis of schizoaffective disorder was based on the lifetime 
assessment of symptoms, and the duration of mood episodes had to be over half of 
the total duration of the illness. Thus, the diagnostic procedure accords with the 
suggested revisions for the DSM-V criteria (Tandon, 2012). The findings of this 
study support the older established interpretation that the prevalence of 
schizoaffective disorder is up to half of schizophrenia (Tsuang et al., 2003) and the 
disorder is more common in women compared with men (Malhi et al., 2008).  
 
The lifetime prevalence of delusional disorder was 0.18%. This estimate was higher 
than in previous clinical (Kendler, 1982) and general population (Hwu et al., 1989) 
samples, but slightly lower compared with the Lundby study (Bogren et al., 2009). 
The higher estimate compared with hospital samples (Kendler et al., 1982) was 
predictable, since only half of the affected subjects had been treated in hospitals. 
The prevalence reported here is probably an underestimation due to lack of insight 
associated with the disorder, and relatively well preserved functional capacity, 
which makes involuntary treatments less likely. As delusions are non-bizarre in this 
disorder, it is extremely difficult to assess the genuineness of delusions in one 
interview, if no other source of information is available. There were several subjects 
in the diagnosis deferred category for whom a delusional disorder was suspected but 
this could not be confirmed. However, with the longitudinal information, persons 
who turned out to have dementia after a year or two after the onset of delusions, 
could be adequately diagnosed as having a psychotic disorder caused by a general 
medical condition rather than delusional disorder (Korner et al., 2009).  
 
Schizophreniform disorder and brief psychotic disorder were rare. When these were 
combined, our results showed equal numbers with Lundby study (Bogren et al., 
2009), but lower than estimates from another study (Cho et al., 2007). The low 
estimate accords with 3-to 6-year follow-up studies of subjects with ICD-10 acute 
and transient psychoses, in which the diagnosis had remained unchanged in only 
34%-40% of the subjects (Castagnini et al., 2008, Singh et al., 2004). Psychotic 
disorder NOS was diagnosed when there was not enough data to assess a specific 
diagnosis. There may be some subjects who would have had the diagnosis of brief 
psychotic disorder if there had been more information available. Nevertheless, these 
results suggest that schizophreniform and brief psychotic disorder are rare disorders 
in the general population.  
 
The lifetime prevalence of psychotic disorder NOS was 0.46%. This means that the 
study failed to assign a specific diagnosis for part of the subjects. In this study, the 
cases given a diagnosis of specific psychotic disorder were easy to diagnose 
according to typical description of the DSM-IV. However, there were several cases 
in which it was not possible to assign any specific psychosis diagnosis according to 
the criteria. Most problems were associated to the lifetime duration and relation of 
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the psychotic and affective symptoms, or the impossibility to differentiate primary 
and psychotic disorder induced by substance use or general medical condition. Also 
other comorbid psychiatric disorders often blurred the “typical” clinical picture. 
While it is somewhat misleading to categorize all these subjects into non-affective 
psychoses, using the NOS category is a common practice (Kirkbride et al., 2006). 
 
 
Prevalence of affective psychotic disorders  
The lifetime prevalence of affective psychoses in the Finnish general population was 
0.59%. The result is again very similar with the Lundby study (Bogren et al., 2009), 
where the 50-year prevalence 0.62% was found. The prevalence of 0.4% affective 
psychoses in the Mini-Finland survey was also very similar (Lehtinen et al., 1991).  
The lifetime prevalence of BPI was 0.24% and 0.12% of subtype with psychotic 
features. Although the prevalence 1% of BPI has been usually presented in the 
literature, in recent World Mental Health Survey, a LTP of 0.6% (range 0.0%-1.0%) 
was found (Merikangas et al., 2011). The variation of estimates has been larger in 
earlier studies (Ferrari et al., 2011, Grant et al., 2005). The result presented here 
cannot be directly compared with the World Mental Health Survey, where the WHO 
CIDI version 3.0 was used. Instead, a very similar result was obtained in the Lundby 
study (Bogren et al., 2009) with methods close to this study. Their slightly higher 
estimate, 0.34%, included also bipolar II and NOS types. The low prevalence of 
bipolar I disorder in this study is not likely to be a consequence of inadequate 
screening, because of the multiple sources of information used. However, there may 
be subjects with bipolar I disorder among the eleven subjects who received a 
diagnosis of bipolar disorder NOS because of inadequate information to assign a 
more specific diagnosis. If all these subjects had bipolar I disorder, the prevalence 
would increase up to 0.39%. 
 
The prevalence and incidence of bipolar I disorder in previous Finnish studies 
(Kieseppä et al., 2004, Räsänen et al., 1998, Sorvaniemi and Salokangas, 2005, 
Veijola et al., 1996, Väisänen, 1975) have been even lower compared with these 
results. Higher LTP 0.53 % for Bipolar I disorder was reported among the young 
adults in the same Health 2000 Survey (Suvisaari et al., 2009). However, the 
estimate also included those who developed the disorder later than the baseline 
Health 2000 Survey, which increased the prevalence. Altogether, it seems that the 
lifetime prevalence of bipolar I disorder in Finland is being towards the lower end, 
but still within the reported range worldwide.   
 
The LTP (0.35%) of MDD with psychotic features was lower than in the few older 
studies (Johnson et al., 1991, Ohayon et al., 2002) but close to the Lundby study 
(Bogren et al., 2009). Diagnosing psychotic depression is challenging in clinical 
settings (Maj et al., 2007), and especially in general population studies. If the 
Discussion 
THL — Research 97 • 2013 84 Epidemiology of Psychotic Disorders 
 
diagnosis of psychotic depression is not assessed and symptoms carefully recorded 
during treatment, it is extremely difficult to evaluate later, whether thoughts, for 
example mood congruent thoughts of guilt are of delusional intensity or not. Thus, 
this study’s estimate is probably conservative. Suprisingly, no statistically 
significant differences were found between genders, even though the LTP of MDD 
is almost twice as common in women compared with men (Pirkola et al., 2006).   
 
The substance-induced psychotic disorders were frequent in the Finnish general 
population, and more prevalent in men compared with women, as could be expected. 
Most of these disorders were alcohol-induced with LTP 0.41%, while LTP for other 
substance-induced psychotic disorders was lower, 0.03%. In young adults (Suokas et 
al., 2010), the proportion of other substances in psychotic disorders was higher. 
Prevalence of substance-induced psychotic disorders are not included in the most 
recent general population studies of psychoses, but comparable 50-year prevalence 
0.59% was found in the Lundby study (Bogren et al., 2009). Almost 10% of first-
admission patients submitted to hospitals have been found to have substance-related 
psychoses, caused mainly by substance other than alcohol (Cantwell et al., 1999, 
Kirkbride et al., 2006). This proportion still underestimates the disorders, as many 
subjects with substance-induced psychotic disorders are not treated in hospitals. 
Concordant with this, the case ascertainment was challenging: half of the subjects 
with substance-induced psychotic disorders were found by the diagnosis of a 
psychotic disorder diagnosis in the hospital discharge register and one third by the 
screen of CIDI positive psychotic symptoms. Case notes were the most important 
source of information in diagnosing substance-induced psychotic disorders.  
 
The lifetime prevalence of psychotic disorders due to GMC was 0.21%, in the age 
group 65 years and over 0.75% and aged 80 and over 1.71%. The prevalence of 
psychosis due to GMC was higher in the Lundby study compared with this study’s 
results. This is not suprising, as in a prospective setting with multiple sources of 
information many more affected subjects could be found. These often elderly 
subjects may not recall their symptoms in one interview and psychosis diagnoses 
may not be recorded during treatment. High prevalence of any psychotic disorder in 
the elderly has been also found in previous studies including individuals over 65 or 
over 80 years old (Alanen et al., 2008, Ritchie et al., 2004, Östling et al., 2009). The 
age range in the previous general population sample studies of psychotic disorders 
has been of lower age (Kendler et al., 1996, Kessler et al., 2005, van Os et al., 2001). 
The majority of subjects (92%) having psychotic disorder due to GMC and over half 
(57.6%) of the subjects with any lifetime psychotic disorder had been diagnosed 
with dementia in the age group of 80 years and over. Lifetime prevalence of 
psychotic disorders due to GMC is clearly an underestimate here, since many 
somatic diseases are associated with psychotic symptoms, which are though rarely 
diagnosed separately and reported in case notes. However, with the information 
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from the case notes, this study was able to identify many subjects with a new onset 
psychosis, subsequently diagnosed with dementia and thus diagnosed with GMC 
related psychotic disorder (Korner et al., 2009).   
 
Sociodemographic features of psychotic disorders (Study II) 
Sociodemographic correlates of non-affective psychotic disorders in the PIF study 
were generally similar to other general population studies (Isohanni et al., 2001, 
Kendler et al., 1996, Kessler et al., 2005, Lehtinen et al., 1991, Miettunen et al., 
2007, Morgan et al., 2012). Being retired was common (70%) among subjects with 
non-affective psychotic disorders, most of them being below the pension age and 
reported having disability pension. One third of subjects with non-affective 
psychotic disorder had reached the pension age (63 years) and 87.0% of those retired 
below that age reported having disability pension.  
 
Being divorced was more common in subjects with affective psychoses than in the 
general population, which fits with earlier studies on bipolar disorders (Kessler et 
al., 1997, Mitchell et al., 2004). Many studies of affective psychoses have found an 
association with low income and education (Grant et al., 2005, Jonas et al., 2003, 
Kessler et al., 1997, Merikangas et al., 2007).  The overall picture is similar 
compared with other studies finding socioeconomic difficulties to be less 
pronounced in affective psychosis group compared with non-affective group (Gureje 
et al., 2002, Waghorn et al., 2012). 
6.3 Geographic variation of psychotic disorders (STUDY II) 
All psychotic disorders were more common in subjects born in rural areas compared 
with those born in urban areas. Other urban-rural differences in the prevalence of 
psychotic disorders were not found. Instead, prominent regional variation was found 
in the LTP of schizophrenia, other non-affective psychotic disorders, and for any 
psychotic disorders, consistent with previous Finnish studies (Haukka et al., 2001, 
Hovatta et al., 1997 Lehtinen et al., 1990, Suominen, 1975). Over two-fold 
differences were detected between the lowest and the highest prevalences. The LTP 
of schizophrenia in Northern Finland (1.8%) was substantially higher than the 90% 
percentile of LTP 1.16% in the review of Saha et al. (2005).  
 
These results may be related to using prevalence data: urban–rural difference in the 
prevalence of schizophrenia is not clear (Saha et al., 2005) even though the 
incidence is higher in urban areas (McGrath et al., 2004). It has to be noted that 
urban-rural differences have mainly been detected in developed western countries, 
mainly in Europe and in USA (Kelly et al., 2010, March et al., 2008). However, 
there are also other western countries, such as Australia, Ireland and Sweden, where 
being born in sparsely populated areas may increase the risk of schizophrenia 
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(Harrison et al., 2003), or rural high prevalence areas have been found (McGrath et 
al., 2001, Torrey et al., 1984, Scully et al., 2004). 
 
The larger regional differences in prevalence according to place of birth than 
according to place of residence in this study agree with earlier findings and support 
the view that area-related environmental factors influence the risk of psychoses early 
during the lifespan (Marcelis et al., 1998, Pedersen and Mortensen, 2001, Scully et 
al., 2004). The highest impact of place of birth was found on schizophrenia: the OR 
7.72 was found for those born in the North compared with those born in the 
SouthWest. 
 
Affective psychoses differed from non-affective psychoses in showing no regional 
variation. The results were consistent with previous studies (Kirkbride et al., 2007b, 
Pedersen and Mortensen, 2006b, Scully et al., 2004). The findings may support 
higher vulnerability to early environmental risk factors in schizophrenia compared 
with bipolar disorder (Murray et al., 2004, 2005). However, the small number of 
cases with affective psychosis in the current study may contribute to the negative 
finding.  
 
The results of this study support the earlier conclusions that the possible risk factors 
for psychotic disorders affecting in the urban environment in many other western 
countries have been, and may still be, more prevalent in the mostly rural Eastern and 
Northern regions of Finland (Haukka et al., 2001). For example at the beginning of 
the 1960s, Eastern and Northern Finland used to be the least developed regions with 
higher infant mortality, shorter duration of pregnancies, and newborns significantly 
more often underweight than in South and West Finland (Palmgren, 1964). These 
regions are still today characterized by high migration rates, high unemployment, 
and lower level of education. Thus, many early environmental risk factors (Cannon 
et al., 2001) for psychoses have existed in these high prevalence areas. 
 
There are also many other factors that might explain the different geographic 
variation of psychotic disorders in Finland compared with many other European 
countries. Differences in sociocultural settings, existence of sparsely populated areas 
and lack of large metropolitan cities may affect the distribution. High latitude (Saha 
et al., 2006) could be one factor affecting the high prevalence of schizophrenia in the 
North. Another possible explanation for regional differences is clustering of genes 
predisposing to psychotic disorders in the East and the North (Hannelius et al., 
2008). Different genetic background of the illness could result from genetic drift 
related to small number of founder families in genetic isolate found from NorthEast 
Finland (Hovatta et al., 1997, Varilo et al., 2000). Diverse populations have also 
been found to differ in the associated risk alleles of schizophrenia in addition to the 
differences in the prevalence (Paunio et al., 2009).  
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No evidence of marked selective migration of subjects with psychotic disorders was 
found. The risk of psychotic disorders was equal in those born in the same area, 
regardless of whether they had later migrated to other regions of the country or not. 
As both good and poor mental health may provoke higher rate of mobility than the 
average, though for different reasons in different places, migration is a difficult issue 
to examine in relation to psychiatric morbidity (Freeman, 1994, Salokangas et al., 
2001, Pedersen and Mortensen, 2006a).  The bias due to regionally variating 
availability and use of services was minimized by including those without 
psychiatric hospital admission and also obtaining information on mental health 
treatments in primary care. 
 
These results support the view that urban life in itself does not increase the risk of 
psychotic disorders (Zammit et al., 2010). Instead, it can be seen as proxy variable 
for a factor or factors that more directly contribute to the risk of schizophrenia 
(Tandon et al., 2008). These factors responsible for, or mediating the association, are 
largely unknown although several different aspects including environmental and 
genetic factors have been hypothesized. Wide diversity of potential candidates 
including for example air pollution, cannabis and social exclusion has been studied 
(Kelly et al., 2010). There may be a synergistic effect between the exposure to urban 
environment and genetic vulnerability to schizophrenia (Van Os et al., 2004) The 
words of Tandon (2008) well describe the situation: “Although it appears that our 
understanding of the causation of schizophrenia has substantially increased over the 
past two decades, what we can confidentially assert is essentially the same - both 
genetic and environmental factors are important, but exactly which specific 
exposures and exactly how they cause schizophrenia is still unclear”. 
 
When investigating determinants of urban-rural variation in schizophrenia, it may be 
important to study both individual and different area level determinants (March et 
al., 2008, Zammit et al., 2010) like social capital (Allardyce et al., 2005, Kirkbride el 
al 2008) and social fragmentation (March et al., 2008), and generally signs of 
deprivation (Losert et al., 2012, Wicks et al., 2010). Moreover, it is likely that the 
risk attributable to ‘urban’ varies significantly in different sociocultural settings in 
different times.  
6.4 Alcohol-induced psychotic disorders (STUDY III) 
This study found LTP of 0.51% of alcohol-induced psychotic syndromes in the 
Finnish population aged 30 and over, 0.96% for men and 0.12 for women. A notably 
high LTP (1.8%), which was higher than schizophrenia, was found in working age 
men. The results are comparable with cumulative incidence of substance-induced 
psychotic disorders in a Swedish (Bogren et al., 2009), as well as with a Norwegian 
study (Astrup, 1989). Higher prevalence of AIPS in men was expected, as alcohol 
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dependence is much more common in men (Pirkola et al., 2006). Consistent with 
previous findings (Tsuang et al., 1994, Schuckit et al., 1995), disadvantaged 
socioeconomic position among people with alcohol-induced psychotic disorders was 
pronounced even when compared with subjects with alcohol dependence without 
psychosis.  
 
A higher LTP of alcohol-induced psychotic disorders than delirium was found 
contrary to earlier hospital samples (Soyka, 2008a,b). As the study sample included 
a random sample of individuals aged 30 and over, many of the subjects with 
delirium could have died already before the sample selection (Lindelius et al., 1974, 
Lindelius and Salum, 1972). Hospital samples (Soyka, 2008a,b) may also produce 
higher estimates of delirium, as the syndrome usually leads to intensive hospital care 
everywhere, but alcohol-induced psychotic disorder may not. The variability 
between the treatment systems in alcohol and drug treatment (Babor et al., 2008) 
affects the accessibility of hospital treatment in subjects with alcohol dependence in 
different countries. High variability between the treatment units for alcohol-induced 
psychotic disorders was also notable in this study. 
 
Assessing the subtype of the disorder according to whether the person had had 
hallucinations or delusions as the most prominent symptoms was challenging. 
Although 98% were diagnosed as having the subtype with hallucinations as 
prominent symptoms, over half of them had also had delusions. This finding is 
consistent with previous results (Achte et al., 1969, Lehtonen, 1996), suggesting that 
diagnostic validity of subtypes in the psychotic disorders related to specific 
substances should be further studied (Matthias et al., 2008).  
 
Supporting earlier results two thirds of subjects with AIPS had comorbid psychiatric 
disorders (Jordaan et al., 2009, Lehtonen, 1996, Tsuang et al., 1995, Schuckit et al., 
1995). The high frequency of comorbidity of different mental disorders with alcohol 
abuse reflects the overlapping environmental, genetic and neurobiological factors 
that negatively influence both types of disorders (Kendler et al., 2003). One view to 
explain this complex issue has been the chronic stress model which suggests how 
the substance abuse of some susceptible patients increases their risk of mental 
disorders and the other way around (Bardy et al., 2005). Sedative or hypnotic 
misuse, which has been associated with more severe alcohol withdrawal episodes 
(Schuckit et al., 1995), was also common in AIPS. 
 
The group of subjects with AIPS had in most cases had a long history of heavy 
alcohol use, as expected (Eyer et al., 2011, Jordaan et al., 2010, Soyka et al., 2008a). 
All subjects had sought some treatment for alcohol problems, although not 
necessarily for psychotic symptoms. In comparison, only 25% of subjects with 
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active alcohol dependence had used some services for alcohol or mental health 
problems during 12 months (Pirkola et al., 2006). 
 
AIPS was also associated with high medical comorbidity (Moos et al., 1994) and 
high use of health services. Subjects with AIPS compared with subjects with alcohol 
dependence had had more hospital treatments (91% and 16%, respectively) and 
among the hospital treated, higher number of treatment episodes (mean 6.5 and 2.8, 
respectively). Twin studies have suggested organ-specific vulnerabilities of alcohol 
damage (Kendler, 1985, Hrubec and Omen, 1981). No evidence was found for this. 
On the contrary, the affected subjects had a wide range of medical consequences due 
to alcohol use. Subjects with alcohol-induced psychosis had more comorbid mental 
disorders compared with subjects with alcohol-induced delirium. Unexpectedly 
there were no differences found in medical comorbidity between these groups 
(Glass, 1989b, Fiellin et al., 2002). These results support the hypotheses that the two 
conditions could be different manifestations of the same process (Glass, 1989a). 
However, the small number of subjects in this study did not allow the detection of 
small differences.  
 
Thirteen percent of subjects with alcohol-induced psychotic syndrome developed 
another psychosis 5 to 10 years later, including 3% who developed schizophrenia. 
Half of the subjects with cannabis-induced psychosis have been found to later 
develop a schizophrenia spectrum disorder, challenging the validity of substance-
induced psychotic disorders (Arendt et al., 2005). The effect of psychotic disorders 
in parents on the risk of developing alcohol-induced psychotic syndrome in patients 
could not be assessed (Arendt et al., 2008, Chen et al., 2005), but paternal alcohol 
problems and paternal mental health problems were associated with developing 
alcohol-induced psychosis or delirium in subjects with alcohol dependence. This 
result is in agreement with earlier studies finding an association between alcohol 
disorders in parents and offspring (Merikangas et al., 1998, Pirkola et al., 2005). 
Specifically the paternal problems could suggest that elevated risk might be related 
to the family environment instead of genetic predisposition only (Jaffee, 2003). The 
complex mechanism of family-related genetic and environmental factors in 
developing psychosis related to alcohol and other substances is a subject for future 
studies.  
 
The mortality of subjects with lifetime AIPS was high: 37% of subjects had died 
during the eight years of follow-up. The age and gender adjusted HR was 20 
compared with the rest of the sample and 12 compared with alcohol dependent 
subjects without psychosis. This accords with the Swedish Lundby study which also 
found that AIPS was a risk factor for high mortality among subjects with alcohol use 
disorders (Mattisson et al., 2011). There were no differences in mortality between 
subjects with history of alcohol-induced psychosis or delirium. These results accord 
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with a Finnish study which found 44% mortality for both groups during a 10 to 15 
year follow-up (Lehtonen, 1996). These high figures inform about the substantially 
elevated mortality risk of subjects with prior history of AIPS compared with the 
general population. 
6.5 Comparison of delusional disorder and subtypes of  
      schizophrenia (STUDY IV) 
 
Delusional disorder compared with subtypes of schizophrenia 
Delusional disorder showed typical features different from paranoid schizophrenia 
and the other schizophrenia subtypes, suggesting good validity of the diagnosis. The 
mean age of onset of delusional disorder was higher and outcome was better 
compared with persons with schizophrenia, consistently with previous research 
(Kendler et al., 1980, 1982). Symptom severity, as assessed by the Major Symptoms 
of Schizophrenia Scale, was very similar to that found by Kendler and Walsh (1995) 
in the Roscommon Family Study sample. The subjects had prominent delusions, but 
low levels of other symptoms.  
 
Compared with the results of this study, some clinical samples have found lower age 
of onset and high levels of depressive symptoms (Hsiao et al., 1999, Maina et al., 
2001, Serretti et al., 1999). It is possible that persons with high level of mood 
symptoms had turned out to have another disorder during their lifetime and persons 
finally diagnosed with delusional disorder represented a group close to the original 
description of paranoia by Kraepelin (Kendler and Tsuang, 1981). Delusional 
disorder and paranoid schizophrenia were different in clinical features, prognosis 
and treatment, as in another recent study (Marneros et al., 2012). 
 The severity of delusions did not differ between groups, but there were differences 
in almost all other symptom dimensions. Subjects with paranoid schizophrenia had 
more severe hallucinations, bizarre delusions, affective deterioration, depressive 
symptoms, bizarre behaviour and avolition, but also more often chronic course and 
poorer outcome of illness than subjects with delusional disorder. Many of the 
differences are expected by the diagnostic criteria, like differences in hallucinations, 
bizarre behaviour and negative symptoms. Mental hospital admissions, and also 
involuntary admissions, were less frequent in subjects with delusional disorder 
compared with subjects with any schizophrenia subtype. Only half of subjects with 
delusional disorder had ever received inpatient treatment. Thus, hospital samples 
may provide a biased picture of delusional disorder. The largest differences were 
seen in the status of current treatment: only 21% of subjects with delusional disorder 
had current treatment contact and 14% used antipsychotic medication, whereas the 
majority of subjects with schizophrenia had both of these. However, over 80% of 
subjects with delusional disorder and without current treatment were rated as in the 
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need for it. Thus, more attention should be paid to the continuity of treatment in 
delusional disorder. Even though the outcome of delusional disorder is better 
compared with paranoid schizophrenia (Marneros et al., 2012), their subjective 
quality of life was second lowest among the psychotic disorders (Saarni et al., 2010).  
 
Subtypes of schizophrenia 
The lifetime prevalences of schizophrenia subtypes in DSM-IV were 0.24% for 
paranoid schizophrenia, 0.42% for undifferentiated schizophrenia and 0.16 % for 
disorganized schizophrenia. Disorganized schizophrenia was more common in 
males than females. No gender differences were found for paranoid or 
undifferentiated subtypes, contrary to older studies (Fenton and McGlashan, 1991, 
Kendler, 1984). The observed gender distributions could be explained by the cross-
sectional sample representing relatively old population and not including earlier 
deceased subjects from the same birth cohorts. Suicide mortality is higher in 
subjects with paranoid schizophrenia than in the other subtypes (Fenton and 
McGlashan, 1991), and higher in males than females (Gruenberg et al., 1985).  
 
Disorganized schizophrenia differed notably from the other schizophrenia subtypes, 
contrary to studies using DSM-III and DSM-III-R that found undifferentiated 
schizophrenia resembling disorganized schizophrenia (Fenton and McGlashan, 1991 
Gruenberg et al., 1985, Kendler et al., 1984, 1994, Korver-Nieberg et al., 2011). 
Subjects with disorganized schizophrenia had a 13-15 years earlier age at onset, 
more severe thought disorder, catatonic symptoms, bizarre behaviour, and negative 
symptoms and worse outcome than subjects with paranoid and undifferentiated 
schizophrenia. None of them were rated as recovered, while a recent meta-analysis 
of recovery in schizophrenia found a median proportion 13.5% (25%–75% quantiles 
8.1%–20.0%) of recovery in schizophrenia (Jääskeläinen et al., 2012). They had 
spent almost ten years in inpatient treatment. This study’s results support the validity 
of DSM-IV disorganized schizophrenia as a schizophrenia subtype. It has good 
descriptive and predictive validity delineating a group of patients with schizophrenia 
with poor outcome. 
 
There were relatively small differences between subjects with paranoid and 
undifferentiated schizophrenia. There were only minor differences in formal thought 
disorder and some negative symptoms between the subtypes and no significant 
differences in age at onset, course and outcome between paranoid and 
undifferentiated schizophrenia. These results suggest that paranoid and 
undifferentiated schizophrenia are more similar in the DSM-IV than in previous 
definitions of the subtypes.  
 
All subjects with schizophrenia had had mental health treatment contact, but 
subjects with disorganized schizophrenia had more often been treated in mental 
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hospitals and more often had current treatment contact. Most subjects with 
schizophrenia were also using antipsychotic medication at the time of the survey 
(64%-92%). Similar results have been found in the Northern Finland 1966 birth 
cohort study, in which 77% of subjects with schizophrenia had a treatment contact 
and 71% were using antipsychotic medication after median 11 years since the onset 
of psychotic disorder (Lauronen et al., 2007).  
 
Altogether, paranoid and undifferentiated schizophrenia as defined by the DSM-IV 
were quite similar disorders. This could reflect the overlapping of the constructs of 
the subtypes and support the subtypes being left out from the DSM-V (Keller et al., 
2011, Tandon, 2012). However, disorganized schizophrenia was a diagnosis with a 
good validity and clinical utility as delineating a group of patients with 
schizophrenia with poor outcome. Instead of subtyping, use of a severity scale is 
proposed for the DSM-V psychotic disorders. It closely resembles the MSSS (see 
Supplement 2). However, the symptom scale in the DSM-V is proposed to describe 
the symptom dimensions during last month while MSSS assessed average severity 
of the symptoms over the entire course of illness. The criterion of a bizarre delusion 
or a Schneiderian first-rank symptom hallucination as a single symptom to judge a 
diagnosis of schizophrenia, has been proposed to be omitted from the DSM-V. At 
the same time bizarre delusions would not exclude delusional disorder (Tandon, 
2012). Thus the results of this study cannot be directly generalized to the proposed 
DSM-V.  
6.6 Methodological considerations 
This study was a nationally representative general population study of different 
psychotic disorders. The major strength was the use of multiple sources of 
information for screening and diagnostic assessment, making possible to assess 
specific psychosis diagnoses. The diagnoses were based on careful evaluation of the 
lifetime information from the case notes and the SCID-I interview.  
  
The agreement between register diagnoses in the National Hospital Discharge 
Register and the best-estimate diagnoses was excellent, with all registers together 
good, but only modest or poor with other screens. Registers were the most sensitive 
screens, while self-reported psychosis and psychosis assessed by the physisian in 
were specific, but sensitivity was poor. Registers were the most important source of 
information also in the Mini-Finland Survey (Lehtinen et al., 1990). The kappa 
value 0.80 for the National Hospital Discharge Register was similar to findings in 
the Northern Finland Birth Cohort study (Isohanni et al., 1997, Moilanen et al., 
2003). In this study, registers were most reliable in ascertaining non-affective and 
affective psychoses, whereas in substance-induced and GMC related psychotic 
disorders the collection of information from several sources was even more 
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essential. Thus, hospital register information is good, but not excellent, for case 
ascertainment of psychotic disorders alone. The lower concordance of other registers 
could be expected, as only three first digits of the ICD diagnoses were recorded 
earlier and therefore all subjects with MDD were also included for screening. It has 
also to be noted that the good agreement of research and register diagnoses 
concerned the group of all psychotic disorders and conclusions on specific diagnoses 
on the basis of this information cannot be made.  
 
Different availability and use of services in different areas is a potential source of 
bias especially in register-based studies (Kelly et al., 2011). However, individuals 
without history of psychiatric hospital admission were included in this study, and 
information from primary care was also obtained. The highest prevalence of 
psychotic disorders was found in the northern, rural parts of the country with long 
distances to nearest hospitals. Thus the bias due to mental health organizational 
differences (Korkeila, 1998, Jörgensen et al., 2009, Salokangas et al., 2001, 2011) 
was minimalized. Mortality in schizophrenia has been highest in the East and the 
North for decades (Jousilahti et al., 1998), but it does not explain regional 
differences in prevalence in this study. However, mortality varies even in small 
regions and may affect the prevalence (Kiviniemi et al., 2010, Rantanen et al., 
2009). As all subjects with schizophrenia had had some treatment contact during 
their lifetime, a great improvement on the coverage of the registers is that 
information from outpatient treatment, both secondary and primary services is also 
possible to be gathered from the beginning of the year 2011 (Rautiainen and 
Saukkonen, 2012). A major problem is that similar high quality register information 
is available only in other Nordic countries (Tsuang et al., 2011 p. 117). This could 
also account for at least part of the high prevalences found in the high latitudes 
(Saha et al., 2006). However, these findings emphasize that several sources of 
information are essential to achieve the best possible coverage of the subjects with 
psychoses in the general population   
 
CIDI alone was not a reliable method of screening psychotic disorders. The high 
proportion of false positive in the psychotic symptoms section was in accordance 
with earlier results (Kendler et al., 1996, Kessler et al., 2005, vanOs et al., 2001), but 
the proportion of false negatives was found to be higher than previously thought 
(Kessler et al., 2005). Less than third of all subjects with psychotic disorders would 
have been found if the only screen would have been the CIDI section G. The section 
F assessing mania symptoms in the CIDI was found to be equally unreliable, finding 
only 25% of the subjects with bipolar I disorder. The results support the view that 
re-interviews and extensive collection of information is of equal importance in 
affective and non-affective psychoses (Kessler et al., 1997, Mitchell et al., 2012, 
Regeer et al., 2004), although the new version CIDI 3.0 seems to be more reliable 
than older CIDI-versions (Kessler and Ustün,  2004, Kessler et al., 2006). To also 
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find earlier unrecognized subjects with affective psychosis, all subjects with 
temporary or permanent pension and medication reimbursement with the diagnosis 
of MDD were included. All subjects treated with lithium or anticonvulsants were 
also included, if they were not selected already by any other screens. Altogether, 
these screens should have found at least those with the most severe course and 
outcome of BPI and psychotic depression. However, in affective psychoses, 
sociodemographic features, social functioning, quality of life or medical 
comorbidity (Partti et al., 2010, Saarni et al., 2010, Viertiö et al., 2012) did not as 
markedly differ from the general population as in non-affective psychoses, 
suggesting that there may not be a bias toward the most severely affected cases. 
Self-reported or phycisian assessed psychotic disorder produced only few false 
positive cases, e.g. the specificity was excellent, supporting previous results 
(Jablensky et al., 2001). However, the sensitivities of these screens were poor. 
 
Also the effect of diagnostic methods was of major importance. Obtaining case 
notes and assessing the best-estimate diagnoses on the basis of all available 
information made possible the estimation of prevalences across all of psychotic 
disorders. Even in semi-structured SCID interview, all subjects were not able nor 
willing to describe their psychotic and affective symptoms or the precise course of 
them accurately enough for a specific diagnosis. This supports earlier findings 
showing that interviews concerning the lifetime presence of mental health disorders 
have a significant risk of missing information (Fanous et al., 2012). General 
population studies, as well as incidence and family studies of psychoses using case 
notes in addition to semi-structured interviews have found more subjects having 
psychotic disorders compared to studies using only self-reported information 
(Bogren et al., 2009, Isohanni et al., 1997, Kendler et al., 1993, King et al., 1994, 
McNaught et al., 1997, Östling et al., 2002)  
 
The oldest subjects might not have remembered psychotic and affective symptoms, 
if these have occurred decades ago. This recall bias was partially overcome by using 
register data, and case note data collected on a lifetime basis also from primary care 
if needed. However, the recall bias may have affected more the estimates of 
disorders with intermittent course like BPI. If all subjects diagnosed with bipolar 
disorder NOS because of insufficient information had BPI, the prevalence would 
rise to 0.39%.   
 
The diagnoses of this study were based on the lifetime duration of the disorder. 
Many subjects had received different psychoses diagnoses during their lifetime. 
Differential diagnosis between different psychotic disorders is difficult especially 
during the acute phases and during the early course of the disorder (Laursen et al., 
2005, Castagnini et al., 2008, Singh et al., 2004, Tohen et al., 2012), as these 
disorders share a number of symptoms (Rosen et al., 2012). Challenges in diagnostic 
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assessment may be reflected as the high prevalence of psychotic disorder NOS 
found also in this study.  
 
Although this study was based on a survey of more than 8000 individuals, the 
number of cases in different disorder categories was still relatively small, leading to 
wide confidence intervals. The response rate of the Health 2000 Survey was 
excellent (93%). In spite of this the effect of nonresponse on prevalence estimates 
was even higher than previously thought (Kessler et al., 2005). Including also 
subjects having a specific register diagnosis of psychosis in the nonresponse group 
still increased the prevalence of all psychotic disorders from 3.06% to 3.48%. This 
study included also homeless and institutionalized persons, population segments that 
might have a high prevalence of psychoses (Fazel et al., 2008, Goldner et al., 2002, 
Kessler et al., 2005, Teesson et al., 2004). However, these findings cannot be 
directly generalized to other studies because the rates of institutionalization and 
homelessness are highly variable between countries.  
 
The lifetime prevalence found here can be regarded as conservative estimates, as 
subjects with a lifetime psychotic disorder not having prior hospital treatment or 
other mental health care contact exist, and may have declined from the Health 2000 
Survey. Especially, LTP of psychotic disorder due to GMC is underestimated. Most 
of the affected subjects are elderly and majority of them are not treated in 
psychiatric field and they are impossible to find for this kind of study, which was 
also supported by one case with psychotic disorders due to GMC in the control 
group. The same concerns substance-induced psychoses, even though the LTP was 
unexpectedly high. 
 
Major limitation in the current study is the exclusion of young adults under 30 years. 
Among young adults, the incidence of schizophrenia is high (Suvisaari et al., 1999), 
but the lifetime prevalence may be lower compared to middle-aged groups. In 
overall prevalence, the exclusion of this age group was probably compensated by the 
higher mortality of subjects with psychotic disorders. However, the exclusion of 
young adults may have lowered the prevalence of bipolar I disorder (Suvisaari et al., 
2009) and substance-induced psychotic disorders (Suokas et al., 2010). The minor 
differences in results between genders in this study could be explained by the age 
group inclusion: young men, among whom the incidence of schizophrenia is high, 
were not included. The oldest age groups were included in this study, compared to 
more usual 54-64 year upper limit. This increased the lifetime prevalence of 
especially delusional disorder and psychoses related to GMC. Exclusion of young 
adults may have also lowered the risk related to urban birth (Haukka et al., 2001). 
The psychotic or psychotic-like symptoms (van Os et al., 2001) in young adults 
especially are a subject for further studies. 
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The LTP figures of AIPS are underestimates, as subjects with alcohol dependence 
are over-represented in the non-response group (Mäkelä et al., 2010). Symptoms of 
the subjects may not be systematically described in alcohol related treatment 
services. Further, diagnoses may neither be coded within these services. There was 
not always enough information on the diagnostic criteria requiring the lack of insight 
related to psychotic symptoms during the psychotic episode. Thus, those who 
specifically sought help for psychotic symptoms were included. This may limit the 
comparison with clinical studies. Other substance-induced psychoses were not 
included in this study, as they were extremely rare in this age group. In young adult 
population the use of of illicit drugs and other substance induced psychoses was 
more common: 91% of the substance-induced psychotic disorders were induced by 
other substance than alcohol among young adults below 30 years (Suokas et al., 
2010) compared with 6% in this age group.   
 
Variability in service systems (Babor et al., 2008) may have had an effect on the 
estimates of AIPS in earlier hospital samples (Soyka, 2008a,b) as well. In some 
countries, psychiatric sector plays a large role in alcohol and drug treatment, while 
in Finland the social service sector has played a major role in treatment. Delirium 
usually contributes to intensive hospital care everywhere, but the variability of the 
treatment systems affects the accessibility of psychiatric hospital treatment in other 
patients with alcohol dependence. Accordingly, only a third of study subjects with a 
first episode of alcohol-induced psychosis were treated in a psychiatric hospital, 
whereas the corresponding figure was over 70% for subjects with delirium. 
Subtypes of schizophrenia have not been included in previous general population 
studies. This study sample is older compared with many clinical studies, thus 
including potentially more late-onset cases, but also those with better outcome, as 
mortality in schizophrenia is high already at young age (Heilä et al., 2005). The 
reliability of the diagnoses in subtypes of schizophrenia was best for disorganized 
schizophrenia, but poor between two raters for the undifferentiated type. However, 
there were only a few cases of individual schizophrenia subtypes, and thus small 
disagreements had a large effect on kappa values (Spitznagel et al., 1985). If 
undifferentiated schizophrenia cannot be diagnosed reliably even in research 
settings, its reliability in clinical practice is questionable. On the other hand, the 
overall reliability of schizophrenia diagnosis was excellent between all raters. 
Diagnostic assessment based on longitudinal information improved diagnostic 
reliability, compared with cross-sectional studies, and the diagnostic challenges 
caused by instability of the diagnoses in the early phases of the illness (Fenton and 
McGlashan, 1991, Fennig et al., 1996) was avoided. Catatonic subtype (Fink et al., 
2009) was too rare to be investigated.  
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6.7 Conclusions 
PIF was the first general population survey reporting the lifetime prevalence of 
specific psychotic disorders in DSM-IV. The results are congruent with a recent 
study from Sweden with comparable methods, as well as with other Finnish studies. 
Schizophrenia, in accordance with earlier Finnish studies, was found to be in the 
highest range of the findings from many countries. In contrast, bipolar I disorder 
was found to be more common than in previous Finnish studies, but still in the lower 
range of international findings. However, schizophrenia and bipolar I disorder 
represent together only less than half of psychotic disorders occurring in the general 
population. In the elderly, delusional disorder and psychoses related to general 
medical condition are common conditions causing suffering and need of care. 
Further studies including also young adults are needed. As psychotic disorders are 
among the most severe and impairing conditions, with a lifetime prevalence 
exceeding 3%, these disorders are a major public health concern. 
 
National registers, especially National Hospital Disharge Register, were most 
reliable in screening non-affective and affective psychotic disorders. The validity of 
register diagnoses of different specific psychosis diagnoses is a subject for further 
studies. The use of multiple sources of information in detecting and diagnosing 
psychotic disorders in future epidemiological studies improves obtaining reliable 
estimates. 
 
Psychotic disorders occur unevenly in different areas. As opposed to many countries 
with high density populations and metropolitan areas, the psychotic disorders are not 
more common in urban areas in Finland. In Finland, the North and the East are high 
prevalence areas of psychotic disorders, particularly of schizophrenia. This should 
be taken into account when resources are allocated to health care. Longitudinal 
studies are needed to investigate the reasons for the regional differences in 
prevalences. Although selective migration was not found in this study, studying 
association of the time lived in the area of birth with psychoses may be also fruitful 
in future studies. Affective psychoses showed no geographic variation, but were also 
associated with different socioeconomic factors than non-affective psychoses. 
Schizophrenia and other non-affective psychoses were associated with considerable 
socioeconomic disadvantage.  
 
Alcohol-induced psychotic disorder and delirium have not been included in recent 
general population studies. However, these syndromes have severe consequences 
when they do appear. The disorders are associated with high number of hospital 
treatments and with high mortality. The important role of alcohol in psychosis 
should be noted in future studies and interventions for those at risk should be 
presented.  Clinical picture of delusional disorder was different from other forms of 
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traditional paranoid psychoses, especially paranoid schizophrenia. All schizophrenia 
subtypes did not show distinctive features proposing diagnostic validity. This 
supports the proposition that the subtypes are being left out from the DSM-V. 
However, disorganized schizophrenia was associated with earlier age of onset and 
more severe symptoms contributing to far longer hospital care. Even if the subtypes 
of schizophrenia may be removed from the next diagnostic classifications, the 
symptoms associated with severe course of illness should be recognized during 
treatment. Attention should be paid to the recognition and treatment continuity in 
delusional disorder.  
 
The studies comprising this thesis represent basic epidemiological studies assessing 
different psychotic disorders, also with the purpose of providing tools for future 
aetiological studies. Including other comorbid psychiatric disorders in addition to 
the whole dimension of psychosis in the future epidemiological studies may also 
help to understand better this complex phenomenon. The high prevalence of 
psychotic disorders found here challenges the old interpretation of evenly distributed 
prevalence of psychotic disorders worldwide. The knowledge and recognition of 
different psychotic disorders and psychotic symptoms should be improved. The high 
and unevenly distributed prevalence of psychotic disorders should also be taken into 
account when resources are allocated to health care. Possibility to work and to have 
an active and meaningful life should also be provided for those affected by a severe 
mental disorder. Health care systems should be developed to provide the best 
possible individual and flexible treatment and active rehabilitation for individuals 
affected by different psychotic disorders.  
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8 Supplements 
Supplement 1.  The questions assessing psychotic symptoms in the M-CIDI section G 
(Wittchen et al 1998). 
   
CG1 Have you ever believed people were spying on you? 
CG2 Was there ever a time when you believed people were following 
you? 
CG2B Have you been convinced that people you saw talking to each other 
were talking about you or laughing at you? 
CG3 Have you ever believed that you were being secretly tested or 
experimented on? 
CG4 Have you ever believed that someone was plotting against you or 
trying to hurt you or poison you? 
CG5 Have you ever been convinced that someone you had not met was in 
love with you? 
CG6 Have you ever been unreasonably convinced that your spouse or 
partner was being unfaithful, although ^AS1^ told you that was not 
true? 
CG7 Have you ever believed that someone was reading your mind? 
CG8 Have you ever been convinced you could actually hear what another 
person was thinking, even though he or she was not speaking? 
CG9 Have you ever been convinced that others could hear your thoughts? 
CG10 Have you ever been convinced that you were under the control of 
some power or force, so that your actions and thoughts were not your 
own? 
CG11 Have you ever been convinced that strange thoughts, or thoughts that 
were not your own, were being put directly into your mind? 
CG12 Have you ever been convinced that someone or something could take 
or steal your thoughts out of your mind? 
CG13 Have you ever been convinced that you were being sent special 
messages through television or the radio, or that a program had been 
arranged just for you alone? 
CG13B Have you felt that a book, or newspaper, or song was meant only for 
you and no one else? 
CG14 Have you ever felt strange forces working on you, as if you were 
being hypnotised or magic was being performed on you, or you were 
being hit by x-rays or laser beams? 
CG17 Have you ever seen something or someone that others who were 
present could not see - that is, had a vision or hallucination when you 
were completely awake? 
CG18 Have you more than once heard things other people couldn't hear, for 
example sounds or something like a voice? 
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CG20 Have you ever been bothered by strange smells around you that 
nobody else seemed to be able to smell, perhaps even unusual odours 
coming from your own body? 
CG20C Have you ever had strange tastes in your mouth that could not be 
explained by anything you had eaten or put in your mouth? 
CG21 Have you ever had unusual feelings on your skin or inside your body 
- like being touched when nothing was there or feeling something 
moving inside your body? 
CG22 Have you ever had a time when you were unable to move at all when 
it wasn't due to a physical or other medical reason? 
CG22A Have you ever had a time when you moved constantly and couldn't 
stop when it wasn't due to a physical or other medical reason? 
 
 
Supplement 2. MAJOR SYMPTOMS OF SCHIZOPHRENIA SCALE  
(MSSS, Kendler et al 1984, Printed by permission from Kenneth S. Kendler) 
 
1. Hallucinations 
1 – Absent   No evidence of hallucinations. 
2 – Mild   Hallucinations either suspected or if present subject is aware 
that it is his imagination   and is usually able to ignore the 
hallucinations. 
3 – Moderate Hallucinations definitely present, and patient generally 
believes in the reality of the hallucinations but the 
hallucinations have little, if any, influence on his behavior. 
Hallucinations are usually not very frequent. 
4 – Severe Hallucinations are usually frequent, and they have a 
significant effect on patient's actions, e.g., he locks doors to 
keep pursuers, whom he hears, away from him. 
5 - Extremely severe 
 Hallucinations are usually very frequent and patient's actions 
based on them have a major impact on him or others, e.g., 
converses with voices so much that he is unable to work. 
2. Delusions 
1 – Absent No evidence of delusions. 
2 – Mild Delusions either suspected or definitely present, but patient 
frequently questions the veracity of his beliefs. 
3 – Moderate Generally has conviction in his false belief, but delusion has 
little, if any, influence on his behavior. 
4 – Severe Delusion has significant effect on patient's actions, e.g. takes 
apart light fixture looking for "bugs". Patient usually 
somewhat preoccupied with delusion(s). 
5 - Extremely severe  
Actions based on delusion have major impact on him and 
others, e.g., stops eating because of belief that food is 
poisoned, boards up apartment and refuses to go out because 
of "mob" waiting to kill him. Patient is usually completely 
preoccupied with delusion(s). 
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3. Bizarreness of delusions 
This item attempts to measure in the delusion the amount of departure from culturally determined 
consensual reality. 
 
1 - Plausible     -Example- The FBI is out to get me because I called up a radio 
talk show and told them I believed in Communism.  
2 – Possible    -Example- May next door neighbors have been putting drugs in 
my coffee so that they can knock me out and have sex with me. 
3 – Unlikely   -Example- They’re trying to confuse me so they may change the 
stories around in my newspaper and come in and change the 
numbers in my telephone book.  
4 – Bizarre     -Example- I know what you’re doing here. I hear the screams at 
night. Don’t think I don’t know that you kill people 
downstairs and then feed them to us.   
5 – Extremely bizarre     
-Example- They’ve got this machine all right. It causes 
mybrains to spin around at nighet and turns them inside out, 
causing me great pain.                                                           
 
 4. Positive thought disorder  
1 – Absent May be difficult to understand due to unnecessary details, 
little education, rambling or other nonpathological 
impediments to clear communication or simple flight of ideas 
which is completely understandable. 
2 - Mild  Occasional instances of though disorder which are of doubtful 
clinical significance and / or produce little impairment in 
understandability 
3 – Moderate Thought disorder definitely present and severe enough to 
produce some impairment in understandability 
4 – Severe Frequent instances of thought disorder which produce definite 
impairment in understandability 
5 – Extremely severe  
Thought disorder is so severe that most of speech is difficult 
or impossible to understand 
5. Catatonic behavior 
1 – Absent No evidence of catatonic behavior 
2 – Mild Possibly present, but not clinically striking, e.g., possible brief 
posturing, some stereotyped gestures, occasional grimacing 
3 – Moderate Definitely present, but only "mild" catatonic symptoms 
present, e.g., stereotyped gestures and gait, frequent grimacing, 
short episodes of posturing 
4 – Severe Definitely present, "full" catatonic symptoms present, 
including catalepsy, negativism, mutism, prolonged posturing 
or episodes of excitement 
5 – Extremely severe  
Patient either persistently cataleptic, stuporous, negativistic 
and mute and has to be fed and bathed  and / or has episodes 
of marked catatonic excitement (prolonged presence of 
purposeless, disorganized, highly excited behavior) requiring 
seclusion and usually restraints. 
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6. Affective deterioration 
1 – Absent No evidence of affective deterioration  
2 – Mild Only subtle evidence of mild blunting or inappropriateness of 
affect 
3 – Moderate Flattening and/or inappropriateness of affect definitely present, 
but not striking. Mild evidence of poor self-grooming or other 
socially inappropriate behavior may be present. 
4 – Severe Flattening and/or inappropriateness of affect is quite evidence 
usually with evidence of poor self-grooming or other socially 
inappropriate behavior 
5 – Extremely severe  
Patient's flattening of affect and / or affective 
inappropriateness are striking. Poor self-grooming and gross 
violations of public "mores" are frequent (i.e. masturbating in 
public, urinating on floor) 
 
7. Negative though disorder 
Poverty of speech and poverty of content of speech 
 
1 –Absent 
2 – Mild 
3 – Moderate Somewhat difficult to communicate with 
4 – Severe  Rather difficult to communicate with 
5 – Extremely severe Effectively mute 
 
8. Depressive symptoms 
Include symptoms of mood, psychomotor activity, cognition and associate neurovegetative 
symptoms. 
 
1– Absent 
2 – Mild 
3 – Moderate 
4 – Severe 
5 – Extremely severe 
 
9. Manic symptoms 
Include symptoms of mood, psychomotor activity, cognition and associate neurovegetative 
symptoms. 
 
1 – Absent 
2 – Mild 
3 – Moderate 
4 – Severe 
5 – Extremely severe 
 
10. Course  
1 - Single episode 
2 - Multiple episodes - full recovery between episodes 
3 - Multiple episodes - partial recovery 
4 - Chronic course with exacerbations  - no true recovery 
5 - Chronic course without exacerbations - no true recovery 
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11. Outcome 
1 – Recovery 
2 – Mild deterioration 
3 – Moderate deterioration 
4 – Marked deterioration 
 
12. Precipitating factors 
 
1 – Absent 
2 – Possible 
3 – Probable 
4 – Definite 
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